Development of multifunctional microgels for novel biomedical applications by Kodlekere, Purva Ganesh
DEVELOPMENT OF MULTIFUNCTIONAL MICROGELS FOR 



























In Partial Fulfillment 
of the Requirements for the Degree 
Doctor of Philosophy in the 












COPYRIGHT© 2015 BY PURVA GANESH KODLEKERE
DEVELOPMENT OF MULTIFUNCTIONAL MICROGELS FOR 























Approved by:   
   
Dr. L. Andrew Lyon, Advisor 
Schmid College of Science and 
Technology 
Chapman University 
 Dr. M.G. Finn 
School of Chemistry and Biochemistry 
Georgia Institute of Technology 
   
Dr. Robert Dickson 
School of Chemistry and Biochemistry 
Georgia Institute of Technology 
 Dr. Philip Santangelo 
Department of Biomedical Engineering 
Georgia Institute of Technology 
   
Dr. Facundo Fernandez 
School of Chemistry and Biochemistry 
Georgia Institute of Technology 
 Dr. Julie Champion 
School of Chemical and Biomolecular 
Engineering 
Georgia Institute of Technology 
   



















To my parents Suneeti (aai) and Ganesh (baba), my sister Madhura, my husband Kaushik 
and 








 I owe everything I have ever achieved, to my parents. I am extremely grateful to 
them for always encouraging me to follow my dreams. They have constantly supported 
me in all my decisions and have been there for me with unconditional love, support and 
confidence, regardless of what they have had going on. There aren’t enough words for me 
to express my appreciation and gratitude towards them, for everything they have done, so 
suffice to say that I would not be where I am without them. I would also like to thank my 
sister, for all her love and support, timely humor and for her confidence in me. She has 
played a pivotal role in pushing me to always do my best, and encouraging me to keep 
pursuing my passions, irrespective of the difficulty of the situation. 
 Next, I would like to thank my husband. While a Ph.D. is extremely rewarding, at 
times it can be very stressful and more so, when both spouses are graduate students. My 
husband has been amazingly supportive, understanding and a constant source of 
encouragement. He has always helped me believe that I am capable of anything, and not 
only has he shared my happiness when I have been successful, but he has always been 
even happier than me, for me, at such times. For all that and more, I am very thankful. I 
am also extremely grateful to my parents-in-law and my sister-in-law, for all their support 
and love. 
 I have to thank my grandparents, aji and ajoba, for being so amazing and always 
teaching us, through example, to be kind to everyone and to always have confidence in 
oneself. Aji was the epitome of strength and independence for everyone in our family. 
Through her constant willingness to learn new things and embrace new technology, while 
 v
still knowing how to stay grounded in reality, she has gifted us with an example we will 
always follow. Her teachings and love will always remain with us. 
 Next, I definitely need to thank my amazing friends. My best friend Aswathy, for 
all the love and compassion, and all the friends I made at Georgia Tech. Classes and 
literature exams were a lot more fun to prepare for, in the company of such amazing 
people. 
 I would also like to express my gratitude for all the members of the Lyon group. 
In particular, I’d like to thank Nicole Welsch for being such an amazing friend and 
mentor. I would also like to thank Mike Smith, who taught me my first microgel 
synthesis when I joined the lab and patiently answered all my questions. I am also 
thankful to Anabel Cartelle, for being an amazing undergraduate student. I am very 
grateful to my collaborators Dr. Erin Dickerson, Dr. John McDonald, Aida Demissie and 
Dr. Robert Dickson, and all other members of the Lyon research group as well, for all 
their advice, support and help.  
 Last but not the least, I would like to thank Dr. Andrew Lyon for being such a 
great advisor. His advice and motivation have been very helpful to me through the course 
of my Ph.D. I have always admired his teaching abilities and his multidimensional 











TABLE OF CONTENTS 
Page 
ACKNOWLEDGEMENTS iv 
LIST OF TABLES xi 
LIST OF FIGURES xii 
LIST OF SCHEMES xvi 
LIST OF SYMBOLS AND ABBREVIATIONS xvii 
SUMMARY xx 
CHAPTER 
1 Introduction 1 
1.1 Polymer-based biomaterials 1 
1.2 Polymeric particles in bioapplications 2 
1.3 Microgels: an introduction 4 
 1.3.1 Microgel synthesis 5 
 1.3.2 Microgel functionality and responsivity to pH 8 
 1.3.3 Conjugations to microgels 9 
 1.3.4 Microgel core/shell architectures 10 
1.4 Microgels in bioapplications 11 
 1.4.1 Microgels in bioimaging 12 
 1.4.2 Microgels for targeted delivery of drugs and small molecule 
therapeutics 13 
1.5 References 16 
2 Design and physicochemical characterization of functional cationic microgel 
constructs 31 
2.1 Introduction 31 
 vii
2.2 Experimental section 34 
 2.2.1 Materials 34 
 2.2.2 Microgel synthesis 34 
 2.2.3 Dynamic light scattering 36 
 2.2.4 Atomic force microscopy 36 
 2.2.5 CBQCA assay for quantification of amines 37 
2.3 Results and discussion 38 
 2.3.1 Synthesis and fundamental characterization of amine functionalized 
microgels 38 
 2.3.2 Quantification of primary amine incorporation in microgels during 
synthesis 46 
2.4. Conclusion 49 
2.5 References 50 
3 Microgel-dye conjugates as viable candidates for the generation of high intensity 
photoacoustic signals 56 
3.1 Introduction 56 
3.2 Experimental section 57 
 3.2.1 Materials 57 
 3.2.2 Microgel synthesis 57 
 3.2.3 Dynamic light scattering 58 
 3.2.4 Atomic force microscopy 58 
 3.2.5 CBQCA assay for quantification of amines 58 
 3.2.6 Tunable resistive pulse sensing 58 
 3.2.7 Conjugation of dyes to microgels 59 
 3.2.8 Absorbance measurements 60 
 3.2.9 Cell culture 60 
 viii 
 3.2.10 Viability studies 61 
 3.2.11 Confocal microscopy 62 
 3.2.12 Generation of photoacoustic signals using microgel-dye conjugates
 63 
3.3 Results and discussion 63 
 3.3.1 Synthesis and detailed characterization of µgel2a and µgel2b 64 
 3.3.2 Conjugation of dyes to microgels and characterization of microgel-
dye constructs 68 
 3.3.3 Viability studies with NIH3T3 fibroblasts 73 
 3.3.4 Generation of photoacoustic signals from microgel-dye constructs  
 77 
3.4 Conclusion 77 
3.5 References 78 
4 Microgel core/shell architectures as targeted agents for thrombolysis 80 
4.1 Introduction 80 
4.2 Experimental section 83 
 4.2.1 Materials 83 
 4.2.2 Microgel core synthesis 84 
 4.2.3 Microgel shell synthesis 84 
 4.2.4 Dynamic light scattering 85 
 4.2.5 Atomic force microscopy 85 
 4.2.6 Fibrin clot formation 86 
 4.2.7 Permeability measurements and perfusion studies 86 
 4.2.8 Production and purification of +6 GFP 87 
 4.2.9 +6 GFP encapsulation studies 88 
 4.2.10 Conjugation of peptides to microgels 88 
 ix
 4.2.11 Clot disruption studies under flow 89 
4.3 Results and discussion 90 
 4.3.1 Development and characterization of core/shell microgels with 
different dimensions 90 
 4.3.2 Flow experiments for analysis of size-based differential localization 
of microgels in fibrin clots 94 
 4.3.3 Encapsulation of +6 GFP in core/shell microgels of different sizes  
 98 
 4.3.4 Clot disruption using microgels conjugated to fibrin-specific 
peptides 100 
4.4 Conclusion 105 
4.5 References 106 
5 Outlook and future directions 112 
5.1 Development of cationic microgels for dye conjugation and high intensity 
photoacoustic signal generation 112 
5.2 Microgels conjugated to fibrin-specific peptides as agents of thrombolysis
 115 
5.3 References 119 
APPENDIX A: The development of ultralow crosslinked microgels: neutral particles 
(NULCs) and small particles (SULCs) 123 
A.1 Introduction 123 
A.2 Synthesis of NULCs and SULCs 125 
A.3 Neutral ULCs (NULCs) 125 
A.4 Small ULCs (SULCs) 128 
A.5 References 129 
APPENDIX B: Additional characterization of cationic microgels and microgel-dye 
conjugates 131 
B.1 Synthesis and characterization of functional cationic microgel constructs
 131 
 x
B.2 Cationic microgels crosslinked with PEG-DA 132 
B.3 pH titrations for analysis of primary amine incorporation 133 
B.4 Conjugation of dyes to amine functionalized microgels 134 
B.5 Viability studies using NIH3T3 fibroblasts 136 
B.6 Photoacoustic signals from microgel-dye constructs 137 
APPENDIX C: Nanogels as vehicles for targeted delivery of siRNA to drug resistant 
ovarian cancer cells 138 
C.1 Core/shell nanogel synthesis and characterization 138 
C.2 Peptide conjugation to nanogels 139 
C.3 In vitro and in vivo studies 139 
C.4 References 142 
VITA   143 
 xi
LIST OF TABLES 
Page 
Table 2.1.1: Reaction conditions and RH values of microgels synthesized at constant 
temperature 39 
Table 2.1.2: Reaction conditions and RH values of microgels synthesized with a 
temperature ramp 39 
Table 2.1.3: Reaction conditions for microgel cores (µgel10) and shells synthesized on 
µgel10 cores  40 
Table 3.1: Comparative values of percentage efficiency of primary amine incorporation 
during microgel synthesis using two different techniques (data from µgel2) 64 
Table 3.2: Population characteristics of µgel2a and µgel2b with comparative microgel 
sizes obtained via tunable resistive pulse sensing using the qNano and 
hydrodynamic diameter obtained using DLS 67 
Table 3.3: Concentrations of conjugated dyes (MGITC and RB) per microgel in 
comparison to dye concentration in solution and efficiency of conjugation 
reactions expressed as a percentage 69 
Table 4.1: Synthesis conditions for small, intermediate and large core particles and 
core/shell microgels 91 
Table A.1: Size characterization of NULCs 126 
Table A.2: AFM image analysis of SULCs 129 
Table B.1: Deswelling data for µgel2b-RB at 37 ⁰C vs. 20 ⁰C 135 
 
 xii
LIST OF FIGURES 
Page 
Figure 2.1: AFM height traces of µgel1 to µgel12 (A to L respectively) deposited on pre-
functionalized glass by centrifugal deposition at 2250 × g for 15 - 20 minutes 
at 25 ⁰C, depending on the microgel type. Images qualitatively demonstrated 
monodispersity of individual microgel suspensions and size differences in 
particles depending on changes in synthesis conditions 41 
Figure 2.2: Incorporation of APMA in moles, in 135 µL of 1 mg/mL solutions of the 
respective microgels (grey bars) and percent efficiency of incorporation of 
APMA (red circles) in conventional microgel populations with varying APMA 
feed ratios (A) and core/shell microgel architectures (B), analyzed via CBQCA 
assay 47 
Figure 3.1: AFM height traces of µgel2a (A), µgel2a-MGITC (B), µgel2b (C) and 
µgel2b-RB (D) deposited on APTMS-functionalized glass by centrifugal 
deposition at 2250 × g for 15 minutes at 25 ⁰C. Images qualitatively 
demonstrated monodispersity of individual microgel suspensions. Solutions of 
µgel2a-MGITC and µgel2b-RB and dried microgel samples are shown 
adjacent to the corresponding images 65 
Figure 3.2: Particle size distribution of dispersions of µgel2a (A) and µgel2b (B) as 
determined through tunable resistive pulse sensing (each graph represents a 
distribution of ~ 215 RqNano values obtained through a total of 3 trials) and a 
schematic demonstrating working of the qNano (C) 66 
Figure 3.3: Microgel-RB conjugates analyzed for dye content via absorbance 
measurements at λmax = 540 nm. Bars with dashed pattern represent conjugates 
µgel1-RB, µgel2-RB and µgel6-RB generated using low ratios of conjugation 
reagents. The brick pattern represents µgel2b-RB with primary amine content 
identical to µgel2-RB, but conjugated to RB using higher concentrations of 
conjugation reagents. Red diamonds represent percent efficiencies of RB 
conjugations to microgels 71 
Figure 3.4: CLSM images of NIH3T3 fibroblasts incubated with varying microgel 
conjugates and concentrations for 24 h, and then stained using Calcein AM 
(green, live cell stain) and EthD-1 (red, dead cell stain) for determination of 
viability. Cells grown at a concentration of 10000 cells/cm
2
 were incubated 
with 0.125 mg/mL µgel2a-MGITC (A), 0.25 mg/mL µgel2a-MGITC (B), 0.5 
mg/mL µgel2a-MGITC (C), 0.125 mg/mL µgel2b-RB (D), 0.25 mg/mL 
µgel2b-RB (E), 0.5 mg/mL µgel2b-RB (F), 0.125 mg/mL µgel2b (G), 0.25 
mg/mL µgel2b (H) and 0.5 mg/mL µgel2b (I). ‘All live’ and ‘all dead’ controls 
(J and K) shown for comparison 74 
 xiii 
Figure 4.1: AFM height traces of S C/S, I C/S and L C/S microgels deposited on 
APTMS-functionalized glass by centrifugal deposition at 2250 × g for 10 - 25 
minutes at 25 ⁰C, depending on the microgel type. Images demonstrated 
spherical particles in all three size ranges 92 
Figure 4.2: DLS measurements performed on S C/S (A), I C/S (B) and L C/S (C) 
microgels generated RH values that demonstrated a slightly greater magnitude 
of pH responsivity at 6 mM ionic strength, than at 50 mM ionic strength 93 
Figure 4.3: Flow studies performed on fibrin clots formed at 3 mg/mL fibrinogen and 1 
U/mL thrombin demonstrated differences in microgel-clot interactions based 
on particle size. Measurements performed at λex = 540 nm, λem = 575 nm. 
Fluorescence intensities were normalized to those of respective (S C/S, I C/S, 
L C/S) reservoir solutions (0.1 mg/mL) 96 
Figure 4.4: Analysis of encapsulation of +6 GFP by S C/C, I C/S and L C/S microgels. 
Fluorescence intensities of supernatants were normalized to those of +6 GFP 
solutions in the respective buffers. Charge screening at higher ionic strength 
was found to be effective in causing differences in encapsulation 99 
Figure 4.5: Trial 1 (A) and trial 2 (B) for flow rate measurements of microgel solutions 
(0.1 mg/mL) following passage through fibrin clots formed at 2 mg/mL 
fibrinogen and 1 U/mL thrombin concentrations. Grey lines indicate flow rate 
of HEPES buffer through the fibrin clots. Pictures of clots after passage of L 
C/S (C), L C/S-GPSP (D), L C/S-AHRP (E) and L C/S-GPRP (F) solutions for 
100 minutes, taken during trial 1. Red arrows indicate extent of microgel 
passage through clots, bringing about partial (D, E) or complete (F) clot 
disruption. The pictures are in agreement with corresponding flow rates (A). L 
C/S-GPRP microgels are seen to be effective in causing complete clot 
disruption in the time frame of the experiment 102 
Figure A.1: AFM height traces of Neutral ULCs (NULCs) deposited on APTMS-
functionalized glass under different conditions. (A) NULCs-1 deposited by 
passive deposition for 1 h from a 20 mg/mL solution. (B) NULCs-1 deposited 
by active deposition at 2250 × g for 30 minutes from a 0.1 mg/mL solution. (C) 
NULCs-1 deposited by passive deposition for 3 h from a 0.1 mg/mL solution. 
(D) NULCs-1 deposited by active deposition at 2250 × g for 7 minutes from a 
0.1 mg/mL solution. (E) NULCs-2 deposited by passive deposition for 1 h 
from a 10 mg/mL solution. (F) NULCs-2 deposited by active deposition at 
2250 × g for 1 minute from a 0.1 mg/mL solution. All images are 20 µm × 20 
µm 127 
Figure A.2: AFM height traces of SULCs deposited on APTMS functionalized glass. (A) 
SULCs-1 deposited by active deposition at 2250 × g for 10 minutes from a 
0.0001 mg/mL solution. (B) SULCs-2 deposited by active deposition at 2250 × 
g for 10 minutes from a 0.001 mg/mL solution. All images are 20 µm × 20 µm
 129 
 xiv
Figure B.1: AFM height traces of microgels synthesized with [NaCl] (A) and [APS] (B) 
above a threshold (specific to the synthesis conditions) leads to the formation 
of misshapen particles (all images are 20µm × 20µm). Microgels were 
deposited on APTMS-functionalized glass by centrifugal deposition at 2250 × 
g for 15 minutes at 25 ⁰C 132 
Figure B.2: AFM height trace of µgelPEG (A), representative height profile (B) and RH 
measured in buffers of different pH values (C). Microgels were deposited on 
APTMS-functionalized glass by centrifugal deposition at 2250 × g for 15 
minutes at 25 ⁰C 132 
Figure B.3: pH titration curves of µgel2 solutions using 0.101 M HCl as a titrant for 
quantification of primary amine groups  133 
Figure B.4: Standard curves for absorbance measurements of malachite green 
isothiocyanate (A) and Rose Bengal (B) solutions at λmax values of 625 nm and 
540 nm respectively  135 
Figure B.5: AFM height traces of µgel1-RB (A), µgel2-RB (B) and µgel6-RB (C) 
represent spherical microgels 135 
Figure B.6: Viability data for NIH3T3 fibroblasts incubated for 24 h with unconjugated 
microgels (blue bars), microgels conjugated to malachite green (green bars) 
and microgels conjugated to Rose Bengal (red bars)  136 
Figure B.7: Photoacoustic signals generated from µgel2a-MGITC (A) and µgel2b-RB (B) 
conjugates incorporated into tissue phantoms  137 
Figure C.1: RH distribution of core/shell nanogels obtained via dynamic light scattering 
(DLS), in phosphate buffer (pH 7, ~ 50 mM ionic strength) 138 
Figure C.2: Delivery of siRNA into HeyA8 tumors. YSA-nanogels were co-injected with 
or without iRGD via the tail vein into mice, and the tumors harvested and 
sectioned. YSA-nanogels (green) and blood vessels stained with CD31 
(magenta) (a) YSA-nanogels +iRGD (b) and analysis of YSA-nanogel to CD31 
pixel area (Image J) demonstrating increased the increased distribution of 
YSA-nanogels in the presence of iRGD (c) 139 
Figure C.3: Uptake of YSA-nanogels by individual tumor cells, determined by flow 
cytometry. The relative nanogel fluorescence values for all groups (N=3, 2 
mg/mouse injected) were normalized by using the Mean Fluorescent Intensity 
(MFI) from each sample and dividing it by the tumor weight (grams). Values 
were determined in the absence (nanogels) and presence of iRGD. 
CTL=Control cells, no nanogels present; SCR=nanogels linked to the SCR 
peptide, used as a control for non-specific uptake of nanogels; YSA=nanogels 
linked to the YSA peptide to direct the nanogel payload to tumor cells 
expressing EphA2 receptors 140 
 xv
Figure C.4: Distribution of YSA-nanogels in HeyA8 tumors and mouse tissues after 
injection of YSA-nanogels alone or in the presence of iRGD. Three mice were 
used for each treatment group, and the relative nanogel fluorescence in tumor 
























LIST OF SCHEMES 
Page 
Scheme 1.1: Typical microgel synthesis leading to the formation of pNIPAm based, BIS 
crosslinked microgels 5 
Scheme 4.1: Experimental setup used for examination of perfusion through fibrin clots. 
Permeability measurements on the clots were first performed using HEPES buffer and 
then the respective microgel solutions were allowed to flow through the clots 95 
Scheme B.1: General representation of a one step synthesis of p(NIPMAm-co-APMA) 
microgels 131 
Scheme B.2: Conjugation reactions utilized for synthesis of µgel2a-MGITC (A) and 

















LIST OF SYMBOLS AND ABBREVIATIONS 
 
Anti-EGFR Anti-epidermal growth factor receptor 
PEG  Poly(ethyleneglycol) 
MRI  Magnetic Resonance Imaging 
LCST  Lower critical solution temperature 
NIPAm  N-isopropylacrylamide 
BIS  N,N′-methylenebis(acrylamide) 
VPTT  Volume phase transition temperature 
NIPMAm  N-isopropylmethacrylamide 
DHEA  N,N′-(1,2-dihydroxyethylene)bisacrylamide 
DMHA  N,O-dimethacryloyl(hydroxylamine) 
ULCs  Ultralow crosslinked particles 
AFM  Atomic force microscopy 
SDS  Sodium dodecyl sulfate 
PS  Polystyrene 
FRET  Fluorescence energy resonance transfer 
EPR  Enhanced permeability and retention 
Dox  Doxorubicin 






   
APMA  N-(3-aminopropyl)methacrylamide hydrochloride 
AEMA  2-aminoethylmethacrylate hydrochloride 
V50  2,2'-azobis(2-methylpropionamidine)dihydrochloride 
APS  Ammonium persulfate 
HEPES  N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) 
CAPS  3-(cyclohexylamino)-1-propanesulfonic acid 
APTMS  3-aminopropyltrimethoxysilane 
PSS  poly(4-styrenesulfonic acid) sodium salt 
RH  Hydrodynamic radius 
DLS  Dynamic light scattering 
CBQCA  (3-(4-carboxybenzoyl)quinoline-2-carboxaldehyde) 
PEG-DA  Poly(ethyleneglycol) (200) diacrylate 
CHES  2-(cyclohexylamino)ethanesulfonic acid 
MES  4-Morpholineethanesulfonic acid 
MGITC  Malachite green isothiocyanate 
RB  Rose bengal 
EDC  N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride 
NHSS  N-hydroxysulfosuccinimide sodium salt 
PBS  Phosphate buffered saline 
DMSO  Dimethyl sulfoxide 
EthD-1  Ethidium homodimer-1 
DH  Hydrodynamic diameter 
CLSM  Confocal laser scanning microscopy 
MG  Malachite green 
 xix
tPA  Tissue-type plasminogen activator 
GPRP  GPRPFPAC 
GPSP  GPSPFPAC 
AHRP  AHRPYAAC 
AAc  Acrylic acid 
AEM  2-Maleimidoethylamine trifluoroacetate salt 
mRhoB  Methacryloxyethyl thiocarbamoyl rhodamine B 
GFP  Green fluorescent protein 
C/S  Core/shell 
AFA  Acrylamidofluorescein  
EMCA  6-maleimidohexanoic acid 
  
  







This dissertation describes the development of multifunctional microgels for 
utilization in novel biomedical applications. The functionality of microgels has been 
utilized for a number of fundamental studies in the past. It has also been exploited to 
facilitate the conjugation of biologically relevant molecules to microgels through a 
variety of routes. This dissertation explores microgel functionality and focuses on 
fundamental characterization and potential applications of microgel conjugates in two 
major biological applications. It also delves into the use of core/shell microgels and 
explores the merits of the utilization of this particular microgel architecture. 
Microgels are solvent swollen, polymer based, hydrogel microparticles that 
demonstrate tremendous versatility in their synthesis. They can thus be synthesized to 
have diverse properties, functionalities and architectures, and to have sizes in the nano- or 
micro- range. Their dimensions make them particularly useful for biological applications, 
because they can be utilized to visualize and/or manipulate cell processes that occur at the 
same length scale. Chapter 1 gives an insight into the history of microgels, along with a 
description of the multitude of biological applications in which they have been 
demonstrated to be useful. 
A number of applications, such as bioimaging, specific targeting and sensing, 
require microgels to be conjugated to different moieties. This can usually be achieved 
through incorporation of functional groups in microgel matrices either during or post-
synthesis. Two such functional groups, that provide opportunities for a range of 
conjugations, are primary amines and carboxylic acids. 
 xxi
Although primary amine functionalities have remarkable potential to be utilized in 
conjugation reactions, the synthesis of stable microgels with high densities of amine 
groups has been challenging due to a variety of reasons. Therefore, we have developed a 
range of functional cationic microgel constructs containing primary amines, in different 
size ranges. Cationic microgels with distinct properties could be obtained through subtle 
changes in reaction conditions and Chapter 2 provides a detailed description of the 
characterization of these microgels. A major focus of this chapter was the quantification 
of amine functionalities present in microgels. This knowledge can be leveraged to 
executing well controlled conjugation reactions. 
Chapter 3 focuses on a model cationic microgel construct and utilization of its 
primary amine functionalities for the conjugation of two dyes with properties that make 
them attractive for use as photoacoustic contrast agents. Through its multivalency, a 
single microgel has the capability to ‘concentrate’ the contrast agent within its small 
volume and this high local concentration of contrast agents was quantified in this chapter. 
Such high concentrations are particularly useful for an application like photoacoustics, 
where irradiation of a single particle can potentially generate very high intensity signals. 
In addition to bioimaging, microgel conjugates also have potential applicability in 
site-specific targeting, through attachment of the relevant moieties to their functionalities. 
Chapter 4 describes the development of such carboxylic acid functionalized microgels, 
targeted to fibrin clots though the conjugation of fibrin-specific peptides. The particles 
developed in this chapter have a core/shell architecture, with the functionalities localized 
primarily to the outer shell. Microgels in three different size ranges were developed, in 
order to investigate their size-based differential localization in porous fibrin clots. These 
 xxii
experiments provided information about microgel interactions with the clot and the 
interplay between microgel dimensions and clot porosity. The conjugation of one fibrin-
specific peptide to microgels, in essence, converted microgels themselves into fibrinolytic 
agents and Chapter 4 describes experiments demonstrating this phenomenon. We 
hypothesize that the multivalency of microgels plays an important role in this function, 
resulting in rapid dissolution of the fibrin clot, at a rate that has not been observed before. 
Finally, Chapter 5 describes some future directions and additional studies that 
need to be performed in order to understand the systems investigated in the previous 
chapters better, and exploit them to the best of their capabilities. Due to the endless 
avenues microgel systems present, their applications are manifold, especially when 
considering biological systems. Obtaining a fundamental understanding of their 
functioning is thus extremely important and will be extremely beneficial for the 









1.1  Polymer-based biomaterials 
 A number of essential components of the human body are comprised of molecules 
made from repeating units. Polysaccharides, proteins and DNA consisting of repeating 
units of sugar molecules, amino acids and nucleic acids respectively are polymers that 
play very important roles in regulating and maintaining normal bodily function. 
Additionally, biopolymers like collagen and fibrin are responsible for specific functions 
like maintaining the integrity of the extracellular matrix and augmenting hemostasis by 
facilitating clotting of blood, respectively. Thus, a number of materials responsible for 
maintaining regulatory function within the body are polymeric in nature. Chitosan and 
alginate are examples of bio-derived polymers obtained from other sources. 
 In addition to the naturally existing biopolymers, a number of synthetic polymers 
have been investigated for their utility as biomaterials. The applications of these 
polymers range from the development of three-dimensional porous scaffolds for tissue 
engineering1-3 to the development of separation membranes,4 construction of prostheses5 
and the generation of vehicles for the delivery of therapeutics.
6,7
 The primary 
requirements for the properties of these materials depend on the application under 
consideration and thus, most often, on the tissue type with which the material will be in 
contact.
8
 Therefore, when compatibility with soft tissue like cardiovascular tissue is 
essential, materials like elastomers are beneficial.
9,10
 For constructs that need to lend 
themselves to circulation in the blood stream, long term survival in the body with least 
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detrimental effects is the requirement that takes priority.
11-13
 While in these applications, 
biodegradability is a desirable quality, for others like those used in some prostheses, the 
ability of the construct to withstand large magnitudes of mechanical stress is a 
prerequisite.14 There exists a vast array of available choices with regards to the identity of 
the constituent polymers and the ability to tune properties of these constructs in a 
controlled fashion. Depending on the specific requirements, various approaches dealing 
with different polymer synthesis conditions or post-synthesis modifications can be 
employed. One of the most significant advances in the field came in the form of a drug 
depot formulation composed of N-vinylpyrrolidine conjugates of glycyl-L-leucine-
mescaline, in 1955.
15 
Thus, the utilization of polymers as biomaterials has gained 
increasing interest in the past six decades. A number of methods have since evolved in 
order to fully exploit the versatility that these systems offer. 
 
1.2  Polymeric particles in bioapplications 
 Nanotechnology has been a booming subject of research, with applications in 







Particularly in the biological field, the dimensions of nano and microparticles make them 
attractive candidates for visualization, manipulation and analysis of cellular processes 
and components. For instance, Gao et al. developed semiconductor quantum dots 
modified with block copolymers attached to tumor-targeting ligands in order to facilitate 
in vivo imaging
25
 and Muhlen et al. generated solid lipid nanoparticles, or SLNs with the 
aim of achieving controlled release of drugs.
26
 Similarly, Huang et al. synthesized gold 
nanorods and conjugated them to malignant cell-specific anti-epidermal growth factor 
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receptor (anti-EGFR) monoclonal antibodies, thus generating constructs that could serve 
the dual purpose of molecular imaging and photothermal therapy.
27
 
 When considering biomedical applications, polymers form an important class of 
materials, as mentioned in the previous section. Polymers like poly(ethylene glycol) 
(PEG) have been used extensively to coat nanoparticles in order to improve their 
circulation time in the body through reduction of uptake by the reticuloendothelial system 
(RES).
28,29
 PEGylation of bovine adenosine deaminase as a method of replacement 
therapy for severe combined immunodeficiency (SCID)
30
 and that of interferons for 
treatment of viral infections like Hepatitis C
31
 are two such examples. Microparticles 
entirely based on PEG have also been generated for added biocompatibility.
32-34
 In a 
similar manner, other polymers have been synthesized to generate nano and micro sized 
composites for applications like the delivery of therapeutics.35,36 A number of these 
composites are multicomponent and thus multifunctional.
37,38
 A polymer by itself can act 
as a drug or sequestrant. One example is poly(allylamines), which work by lowering 
serum phosphorus and parathyroid hormone, or controlling cholesterol absorption, by 
binding phosphates or bile acids respectively.
39,40
 Alternatively, they may be utilized as 
delivery vehicles for therapeutic agents either in the form of polymer-drug conjugates
41,42
 
or as polymeric assemblies such as micelles,
43,44
 which can be loaded with the relevant 
therapeutic agent.45,46 In addition to their efficacy as delivery agents, polymeric 
constructs have also been researched for their utility in several imaging modalities, either 
by themselves or in conjunction with contrast agents that have known imaging 
capabilities. Thus, conjugated polymers have been developed as detection agents of 
specific nucleic acids and proteins.
47
 On the other hand, contrast agents have been 
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conjugated to polymers to form constructs with potential applicability in magnetic 
resonance imaging (MRI)
48,49
 and fluorescence imaging.
50-52
 One class of polymeric 
particles in the nano- to micro- scale, that have been demonstrated to be promising in a 
wide range of biomedical applications, are microgels. 
 
1.3 Microgels: an introduction 
 Microgels are polymer-based, colloidally stable nano or microparticles. Similar to 
their bulk hydrogels counterparts, they are solvent swollen. Due to the flexibility 
available in their synthesis conditions and components, microgels can be synthesized to 
have dimensions in the nano or micro range. They can also have different mechanical 
properties,53,54 optical properties55,56 and functionalities. Some examples of nonionic 







 Above a characteristic 
temperature known as the lower critical solution temperature (LCST), polymer chains of 
these molecules collapse upon themselves. This entropically driven coil to globule 
transition takes place through expulsion of water into the surrounding environment, due 
to polymer-polymer interactions being favored over polymer-solvent interactions. 
Microgels synthesized from these monomers also possess this thermoresponsivity. N-
isopropylacrylamide (NIPAm) is a well explored monomer for microgel synthesis. Its 
polymer pNIPAm has an LCST of 31 ⁰C and hence, pNIPAM based microgels 
demonstrate thermoresponsivity around this temperature. Since this transition is 
reversible through a change in temperature, microgels have several potential applications 




 and in sensing devices.
61
 The responsivity of microgels extends to other stimuli as 
well
62
 and this responsivity along with numerous other application dependent desirable 
properties like biodegradability63-66 and extreme deformability54 can be engineered into 
constructs through modifications in their syntheses. 
 
1.3.1  Microgel synthesis 
 One of the earliest examples of microgel synthesis was reported by Pelton et al. in 
1986.
67
 In a typical synthesis (Scheme 1.1), an aqueous solution of NIPAm and a 
crosslinker such as N,N’-methylenebisacrylamide (BIS) is heated and polymerization is 
initiated at a temperature above the LCST of pNIPAm. The thermoresponsivity of 
pNIPAm based microgels translates into their synthesis and thus, initiation triggers the 
formation of pNIPAm chains that undergo the coil to globule transition described above. 










Scheme 1.1. Typical microgel synthesis leading to the formation of pNIPAm based, BIS 
crosslinked microgels 
 6
 The microgels thus formed also possess thermoresponsivity and display it in the 
form of a volume transition, i.e. at a temperature above 31 ⁰C, these spherical particles 
collapse and expel water, causing a dramatic change in their volume. Thus, in reference 
to microgels, this temperature is referred to as a volume phase transition temperature 
(VPTT).  
 While pNIPAm has been used extensively in order to study the kinetics of 
microgel syntheses,
64
 mechanical properties of microgel assemblies
68
 and various 
architectures of the constructs, when considering utilization in conjunction with 
biological systems, its utility specifically spans those areas warranting collapsed particles 
at the physiological temperature of 37 ⁰C.60 Some applications, however, may require 
solvent swollen microgels at this temperature. One example involves time controlled 
delivery of loaded therapeutics,
69
 which may not be accomplished since microgel density 
and hence interactions between the polymer chains and loaded therapeutics change 
drastically following collapse. A second example relates to the utilization of microgels in 
imaging, where collapse may lead to a reduction in the signal due to interference because 
of increased scattering or self-quenching of dyes present within or conjugated to the 
microgel matrix. For such applications, a methyl substituted relative of NIPAm is 
promising. N-isopropylmethacrylamide (NIPMAm) when polymerized, forms pNIPMAm 
with an LCST that is elevated when compared to that of NIPAm, due to the methyl 
substitution on the α carbon of the backbone. When microgels composed of primarily 
pNIPMAm are synthesized, their VPTT is therefore also elevated, at 44 ⁰C, thus causing 
them to remain swollen at the temperature of the human body. 
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 In addition to the primary monomers, various additional synthesis components 
and conditions can be altered in order to generate particles with desirable properties. For 
instance, different comonomers may be used in order to impart differential functionality 
to the microgels. These will be discussed in more detail in section 1.3.2. Furthermore, 
polymerizable fluorescent comonomers may be introduced during the synthesis in order 
to facilitate the incorporation of the fluorescent entity throughout the polymer matrix. 
This is useful for investigations on optical properties or for the purpose of visualization of 
particles in future investigations.
70,71
 A range of bifunctional crosslinkers can also be 





 and polyethylene glycol dimethacrylate.
73
 Some crosslinkers 
like N,N′-(1,2-dihydroxyethylene)bisacrylamide (DHEA)74 and N,O-
dimethacryloyl(hydroxylamine) (DMHA)65 have been utilized in order to introduce 
biodegradability as described earlier. Variation in crosslinker identity and crosslinking 
density can also aid manipulation of reaction kinetics, leading to changes in mechanical 
properties of the microgels.
75,76
 pNIPAm based microgels can also be synthesized without 
a crosslinker, as shown by Gao et al. in 2003.
77,78
 Recently, we synthesized ultralow 
crosslinked particles or ULCs (refer to Appendix A) in a range of sizes (diameters of ~ 
400 nm to ~ 4 µm) and characterized their deformability through studies on surface 
spreading, pore translocation, and Atomic Force Microscopy (AFM) nanoindentation.54 
 Microgel size can be partially controlled through the introduction of a specific 
concentration of initiator. In general, utilization of a high concentration of initiator 
creates a bias towards the formation of nucleation sites vs. the propagation of polymer 
chains, thus leading to the development of a large number of smaller particles. The use of 
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a lower temperature of initiation also influences microgel size, generally leading to the 
formation of larger particles due to a smaller number of initiation sites being generated 
and chain propagation being favored. Additionally, microgel size and stability may also 
be altered through the use of a surfactant like sodium dodecyl sulfate (SDS).79 Higher 
concentrations ordinarily cause early stabilization and hence smaller sizes of formed 
particles. 
 Almost all properties described above have the ability to be influenced by the 
presence and identity of comonomers used. However, the chief reason for utilizing 
comonomers is more often the introduction of functionalities within microgel matrices, 
the presence of which can be leveraged to a wide range of post-synthesis modifications. 
 
1.3.2  Microgel functionality and responsivity to pH 
 The introduction of functional groups in microgel matrices can either be done 
during particle formation or as an additional step following synthesis. This may be done 
for the purpose of enabling conjugations of pertinent moieties to the matrices, for 
imparting responsivity to additional stimuli such as pH to the particles, or for performing 
fundamental investigations on polymerization kinetics and the effects of the presence of 
charged species.80 The presence of a large number of polymerizable functional group 
containing monomers provides a range of options for appropriate selection depending on 







 Depending on the similarities or 
differences in polymerization kinetics of the primary and comonomers and their 
reactivity ratios, diverse combinations of these entities can be utilized. 
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 If functionalities with pKa values in the relevant range are introduced, pH 
responsivity can be introduced into microgels, which manifests itself in form of microgel 
volume phase transitions, when the functional groups are uncharged. Examples of some 
anionic comonomers that have been introduced in microgel matrices during syntheses are 
acrylic acid, fumaric acid, vinyl acetic acid84 and 4-vinylphenylboronic acid.85 Similarly, 





and poly(2-(diethylamino)ethyl) methacrylate (PDEAEMA)
88
 have also been 
incorporated into microgel matrices. It is worth noting that not all these functionalities 
lend themselves to the conjugation reactions mentioned before, since opportunities for 
substitutions are not available in all the above examples. When such ionic functionalities 
are distributed throughout the interior of microgel particles, depending on the pKa of the 
comonomer, at a pH when the functional groups are charged, the presence of counterions 
and accompanying water causes the microgels to be swollen. A change of pH to a value 
on the other side of the pKa spectrum causes the functionalities to be uncharged, thus 
making the microgels deswell through expulsion of the water associated with the 
counterions. This pH responsivity of microgels is thus useful to gauge the incorporation 
of functional groups and in applications relating to delivery of therapeutics through 
expulsion of loaded cargo.
89 
 
1.3.3  Conjugations to microgels 
 The introduction of functional groups in microgel matrices either during or post 
synthesis is vital for permitting covalent conjugations of a vast number of species. The 
conjugates generated have been demonstrated to be useful in a wide array of applications. 
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For example, microgels conjugated to aptamer probes have been synthesized for the 
detection of proteins by Srinivas et al.
90
 Other microgel based detection systems include 
microgel-DNA oligonucleotide conjugates immobilized on paper strips for DNA 
detection91 and glucose sensing devices. The latter have primarily exploited the 
interaction between glucose and 3-aminophenylboronic acid (APBA) leading to swelling 
responses
92
 or the use of etalons to observe shifts in reflectance peaks.
93
 Another 
interesting utilization of bioconjugation was in the generation of hemoglobin loaded 
microgels, developed by Chen et al., for utilization as oxygen carriers, or artificial red 
blood cells.
94
 Similarly, the generation of artificial platelets has utilized bioconjugation of 
a fibrin-specific species onto microgels.
95
 A number of constructs have been developed 
for specific targeting to cancer cells for imaging or the delivery of therapeutics. 
Therefore, conjugations of a variety of species to microgels can be carried out and 
tailored to particular applications to yield highly effective systems. 
 
1.3.4  Microgel core/shell architectures 
 In addition to the versatility they provide in terms of size and functionality, 
microgels also can be synthesized to possess different architectures such as core/shell, 
core/double shell, hollow and yolk/shell particles.
38
 All of these can be considered as 
derivatives of the primitive core/shell structure, which is relatively straightforward to 
synthesize and is extremely valuable in applications that require dual or multiple 
functionality. 
 The synthesis of core/shell microgels with multifunctionality has been reported by 
a number of research groups.
96-99
 The core may be hard sphere based, composed of a 




 or metal nanoparticles
105
 or it could constitute 
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a porous network of polymers such as pNIPAm or pNIPMAm.
106,107
 Core/shell microgel 
constructs have thus been developed from a number of different constituents, by utilizing 
a range of techniques, leading to the generation of particles with varying properties and 
suited to diverse applications such as catalysis,
108
 delivery of therapeutics
71
 and 
imaging.109 The development of core/shell microgel architectures with degradable 
components has been particularly useful for studying the relationship between the two 
components.
107,110
 Incorporation of a degradable crosslinker such as N,N′-(1,2-
dihydroxyethylene)bisacrylamide (DHEA) can generate hollow particles, such as those 
reported by Nayak et al.
74
 Recently, Tripathi et al. demonstrated the utility of such 
thermoresponsive constructs in separation and catalysis.111 Geest et al. developed dextran 
based self-exploding microgels with the shell in the form of a semipermeable membrane 
that would rupture upon core degradation, thus releasing the encapsulated cargo.
112,113
 
The core/shell architecture was developed further using a three step synthesis and a 
second shell was added onto the first, degradable shell, by Hu et al. Degradation of the 
first shell generated multicompartment particles, and is useful for enhanced isolation of 
the microgel components.114 
 
1.4  Microgels in bioapplications 
 As is evident from the previous section, microgels have tremendous potential for 
utilization in conjunction with biological systems. From bioimaging to drug delivery and 
diagnostics, the versatility of microgel constructs makes them amenable to utilization in 
an array of such applications. In addition to their biologically relevant dimensions, the 
possibilities of suitable bioconjugations and opportunities to tune their biocompatibility 




1.4.1 Microgels in bioimaging 
 While a few of the aforementioned biological applications require the microgels 
to lend themselves to be imaged while serving their primary purpose, some microgels 
have been developed with the sole purpose of generating imaging agents. When 
considering optical probes, these constructs can broadly be divided into three different 
classes. The first of these includes particles with analyte recognition ligands, which can 
be used as sensors for DNA, proteins or other biomolecules, as discussed earlier (refer to 
section 1.3.3). The second category comprises of contrast agents like dyes either 
incorporated into microgels during polymerization or conjugated to them following 
synthesis, thus generating constructs with a high local concentration of the contrast agent 
in the microgel volume. This is beneficial for generating high intensity output signals. 
The last category combines optical properties of contrast agents with the ability of 
microgels to deswell on receiving an external stimulus. On undergoing a volume phase 
transition, microgels cause a change in the physicochemical environment of the contrast 
agent, which can be detected through a change in the optical signal. Some groups have 
utilized a combination or modified versions of these techniques. For example, Zhou et al. 
developed a ratiometric imaging/sensing system for antigen presenting cells (APCs) in 
the form of core/shell microgels with oxygen and pH sensitive probes in the core and 
shell respectively. These particles with a polystyrene (PS) core and pNIPAm shell were 
found to be biocompatible and have potential applications in disease diagnosis and the 
investigation of cellular metabolic processes using a multi-sensor platform.
109
 Similarly, 
pNIPAm microgel based ratiometric probes for glucose and temperatures were generated 
by Wang et al., by incorporating glucose recognizing APBA residues and fluorescence 
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resonance energy transfer (FRET) donor and acceptor dyes within microgel matrices.
115
 
Furthermore, microgel-quantum dot hybrids have also been developed using numerous 
strategies and have been demonstrated to be useful in high quality photoluminescence 
imaging116 and detection of biomolecules.117 In addition to optical imaging, microgel 
systems have also been modified to lend themselves to magnetic resonance imaging 
(MRI). In one technique, microgels themselves were developed as the contrast agents by 
reacting manganese tetra(3-vinylphenyl) porphyrin with NIPAm or NIPMAm using free 
radical emulsion polymerization. This system can be utilized to monitor small changes in 
temperature using MRI, due to thermoresponsivity of the polymers.
118
 Another recent 
demonstration of microgels for MRI involved the encapsulation of dye (as a drug mimic) 
loaded temperature sensitive and non-temperature sensitive liposomes within alginate 
microgels, following loading of a T1 MRI contrast agent into the liposomes. The 
microgels were crosslinked with a T2 MRI contrast agent and this arrangement thus 
facilitated simultaneous visualization of drug release and the microgels.
119
 Thus, microgel 
constructs have been built for compatibility with some imaging modalities. However, this 
is a continuously evolving field and new developments related to newer imaging 
platforms continue to develop due to the abundance of opportunities that are being 
realized. 
 
1.4.2  Microgels for targeted delivery of drugs and small molecule therapeutics 
 The porous nature of microgels and the ability to incorporate functionalities 
within their network (refer to section 1.3.2) have led to the generation of dually 
functional microgels, for specific targeting and delivery of therapeutics. Although some 
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systems of this nature have been discussed briefly in the preceding sections, this segment 
aims at discussing in detail, the range of systems developed specifically for this purpose 
with intricacies related to a few examples. 
 The delivery of chemotherapeutic agents specifically to cancer cells has been a 
prominent area of research, predominantly in order to mitigate off-target effects of cancer 
drugs like doxorubicin, such as myelosuppression and cardiotoxicity.
120
 Targeted 
delivery systems are thus an important field of research and microgels form an important 
class of such materials. While passive targeting methodologies rely on the enhanced 
permeability and retention (EPR) effect due to abnormal vasculature at tumor sites,
121
 
active targeting is achieved by taking advantage of differential expression of certain 
moieties on cancer cells and their specific interactions with molecules that can be 
conjugated onto microgels. The types of interactions utilized for this targeting have been 
multifarious. While Nayak et al. targeted the folate receptor, utilizing the excessive folic 
acid demand specific to cancer cells,
122
 Lu et al. utilized methotrexate (MTX), an analog 
of folic acid for simultaneous targeting and anti-cancer activity through interference in 
the folate metabolic pathway. The nanogels used by this group were gold nanoparticle 
loaded, polyacrylamide based particles.
123
 Das et al. conjugated microgels to transferrin, 
with the goal of targeting the transferrin receptor that is upregulated in cancer cells and 
loaded the particles with doxorubicin (Dox), an anti-cancer drug.124 Zhang et al. utilized 
the same interaction, but with chitosan microgels.125 Thiol functionalized microgels were 
developed by Cook et al. as delivery systems for chemotherapeutic agents to the urinary 
bladder.
126
 In addition to the delivery of anti-cancer drugs, RNA interference
127
  has been 
explored in order to combat multidrug resistance developed by cancer cells through gene 
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silencing. Small RNAs like small interfering RNA (siRNA) and microRNA (miRNA)
128
 
have been demonstrated to be useful for this purpose, but reliable methods for their 
delivery still remain elusive. Dickerson et al. developed a nanogel based siRNA delivery 
vehicle, by conjugating functional groups on microgel shells to peptide mimics of the 
ephrin-A1 ligand, which specifically targets the EphA2 receptor that is overexpressed in 
cancer cells.
71,129
 The difference in internal temperatures of healthy cells (~ 37 ⁰C) and 
tumor cells (~ 42 ⁰C) has also been exploited as a possible method of targeting by Rubio-
Retama et al.
130
 and Teng et al.
131
 Additionally, core/shell poly(vinyl alcohol)-hyaluronic 
acid microgels were synthesized via click chemistry by Kupal et al. The specific targeting 




 In addition to the delivery of anti-cancer agents, microgel based systems have also 
been developed for delivery of other therapeutics to specific cells or organs. For example, 
oxidized starch microgels were demonstrated to be effective in protection of encapsulated 
anthocyanins from degradation in the upper gastric tract, for efficient delivery to the 
intestine by Wang et al.
133
 Similarly, carboxymethyl starch/β-cyclodextrin microgels 
were developed for prevention of release of ascorbic acid before it reached the intestine. 
In this case, the therapeutic was incorporated into the delivery vehicle in the form of a 
microgel-ascorbic acid inclusion complex.
134
 With the goal of generating an anti-
osteoporotic effect and reducing uptake of particles by the liver, Heller et al. developed 
dextran based nanogels with click-able functional groups for biphosphonate ligand 
attachment.
83
 These modular microgels are promising for delivery of therapeutics 




 The field of targeted delivery using microgels has thus grown tremendously over 
the past few years. The utilization of microgels in a number of biological applications is 
also gaining interest as the potential of different microgel constructs is being realized. 
The following chapters will focus on the detailed characterization of functional cationic 
microgel constructs (Chapter 2) and conjugations to these particles for generating 
imaging agents (Chapter 3). The utilization of core/shell microgel constructs in novel 
biomedical applications will also be discussed in the following chapters. 
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2.1 Introduction 
 The widespread applicability of colloidal conjugates has led to the development 
of a range of systems that can be utilized in controlled conjugations. Through different 
routes, such constructs have been developed for various purposes like the delivery of 
therapeutics, imaging, and solubilization of active agents.
1-6
 A number of these constructs 
have the advantage of being in the nano- to micro- range, which makes them increasingly 
attractive for employment in conjunction with biological systems due to their similarity in 
dimensions to specific cells and cellular components, and thus increased control over 
processes happening at this scale.
7-10
 Furthermore, the opportunity to tune their size to 
match specific applications provides additional advantages.11 Microgels constitute a 
promising sub-class of such materials. Similar to their bulk hydrogels counterparts, 
microgels are water swollen, yet can be synthesized to have sizes ranging from tens of 
nanometers to a few microns.
12,13
 They have been demonstrated to be beneficial in a wide 











The versatility in their synthesis also makes it possible to make them more 'biofriendly' 
through the utilization of biocompatible constituent polymers
18
 and degradable 
crosslinkers,
19,20
 further enhancing their suitability for use in biological systems. 
 A number of species such as single chain antibodies,21 peptides22 and biologically 
relevant small molecules23 have been conjugated to microgels through suitable reactions 
in order to make the resulting constructs useful for some of the applications mentioned 
above. This has primarily been made possible through the introduction of functional 
groups within the microgel matrices during synthesis, by copolymerization with 
molecules containing the desirable functionalities. Thus, microgels with versatile 
functionalities such as carboxylic acid groups, amine groups and others
24,25
 have been 
synthesized in the past. Microgels being porous networks, the presence of these entities 
throughout their matrix provides the potential for multivalency to an even higher extent 
than that observed in comparable hard sphere microparticles, which are only capable of 
displaying functionalities on their surface. This high density display of functional groups 
is useful for development of conjugates with very high local concentrations of the 
relevant biomolecules. One such functional group that can be incorporated in microgel 
networks is the amine group. The incorporation of amine groups brings with it the 
opportunity to perform numerous conjugation reactions to a range of functional groups on 
the biomolecules, such as NHS esters, isocyanates or isothiocyanates, acyl azides, 
carbodiimides, and aldehydes.26 Thus, keeping the potential of these systems in mind, 
cationic polymeric particles containing amine groups have been synthesized and 
characterized by several groups in the past.
27-30
 Both N-isopropylacrylamide (NIPAm) 









 A detailed description of the 
various constructs that have been synthesized from several different constituent 
monomers has been provided by Ramos et al.37 In spite of their manifold merits though, 
the extensive utilization of amine functionalized microgels has been hindered due to the 
inherent limitations of their syntheses as noted by Thaiboonrod et al.
36
 and Farley et al.
38
 
The main issue relates to the stunted incorporation of amine containing comonomers 
during synthesis and therefore, an inability to generate stable, monodisperse solutions of 
large colloids with a high density of amine groups. Microgels with diameters of ~ 1 µm 
particularly, have remarkable potential in being useful for the visualization and 
manipulation of biological processes occurring at this length scale. However, a simple, 
reproducible, one step reaction for generation of colloidally stable microgels in the 
micrometer range, with a high density of amine groups has remained largely elusive. This 
has necessitated the employment of multi-step, complicated pathways in order to achieve 
the desirable end products.
38,39
 
 In the work presented here, a series of primary amine functionalized microgels 
were developed in different size ranges and with varying amounts of amine groups. 
Having been synthesized primarily from the monomer N-isopropylmethacrylamide 
(NIPMAm) leading to the formation of the thermoresponsive polymer pNIPMAm, the 
loosely crosslinked microgels are swollen at 37 ⁰C, which makes them viable candidates 
for applications requiring colloidally stable particles at the physiological temperature. We 
have demonstrated that simple one step syntheses can be utilized to generate 
monodisperse solutions of cationic microgels in a reproducible manner, with synthesis 
conditions being altered to optimize formation of the end product. For comparison, a two-
step approach for the synthesis of core/shell microgels is also investigated. All microgels 
 34
were analyzed in detail for their primary amine content. This analysis is crucial for any 
system that has the potential to be used for well controlled conjugations. 
 
2.2 Experimental section 
 
2.2.1 Materials  
 All materials were purchased from Sigma-Aldrich unless specified otherwise. The 
primary monomer N-isopropylmethacrylamide (NIPMAm) was purified via 
recrystallization from n-hexane (J.T. Baker). The comonomer N-(3-
aminopropyl)methacrylamide hydrochloride (APMA, Polysciences, Inc.), crosslinker  
N,N′-methylenebis(acrylamide) (BIS), NaCl, cationic initiator 2,2'-azobis(2-
methylpropionamidine)dihydrochloride (V50), anionic initiator ammonium persulfate 
(APS), buffer preparation materials sodium dihydrogen phosphate, N-(2-
hydroxyethyl)piperazine-N′-(2-ethanesulfonic acid) (HEPES), 3-(cyclohexylamino)-1-
propanesulfonic acid (CAPS) and sodium borate, 3-aminopropyltrimethoxysilane 
(APTMS) and poly(4-styrenesulfonic acid) sodium salt (PSS) for substrate 
functionalization for AFM imaging, ethanol, isopropanol and acetone were all used as 
received. Solutions were prepared using distilled water, deionized to a resistance of 
18 MΩ (Barnstead E-Pure system) and were filtered through a 0.2 µm Acrodisc syringe 
filter before use. 
 
2.2.2 Microgel synthesis  
 Microgels were synthesized by free radical precipitation polymerization. In a 
typical synthesis, NIPMAm, BIS and APMA in the relevant molar compositions (refer to 
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Table 2.1 for monomer feed ratios) were dissolved in 49 mL distilled, deionized water to 
a total monomer concentration of 140 mM (except for µgel11 and µgel12) along with 
sodium chloride, where pertinent, at the indicated concentration. The resulting solution 
was filtered through a 0.8 µm Acrodisc syringe filter and introduced into a 100 mL three 
necked, round bottom flask along with a magnetic stirrer. The flask was fitted with a 
thermometer, condenser and N2 inlet and introduced into an oil bath, which was heated at 
100 ⁰C/h. Stirring was kept constant at 400 RPM and the solution was purged with N2. 
Once the temperature was stable at 70 ⁰C, 1 mL of the initiator (APS or V50) was added 
after filtration through a 0.2 µm Acrodisc syringe filter. The reaction was allowed to 
proceed for 4 h under a N2 blanket, after which it was cooled down to room temperature. 
The solution was then filtered through glass wool.  
 For the syntheses performed on a temperature ramp, a similar procedure was 
utilized. The monomer solution was heated until it reached a stable starting temperature 
of 50 °C. Polymerization was initiated at this temperature with the addition of 1 mL of a 
filtered V50 or APS solution and following initiation, the reaction solution was heated to 
a final temperature of 70 °C using a ramp rate of 30 °C/h. 
 Core/shell synthesis details have been previously reported.22,40 In a typical 
synthesis, 39 mL of a filtered monomer solution consisting of NIPMAm, BIS and APMA 
was introduced into a reaction flask along with 10 mL of the purified core (µgel10) 
solution. This reaction solution was heated to a stable temperature of 65 °C while being 
continuously stirred and purged with N2. Polymerization was initiated at this temperature 
with the addition of 1 mL of filtered V50 solution. 
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 All microgels were purified by pelleting via ultracentrifugation (Beckman Coulter 
Optima MAX-XP) at 120,700 - 214,600 × g for 30 - 60 minutes, depending on the 
microgel type. This was followed by removal of the supernatant and resuspension in DI 
water. This process was repeated four times, after which the microgels were lyophilized 
prior to characterization. 
 
2.2.3 Dynamic Light Scattering  
 Hydrodynamic radii (RH) of the microgels were determined via dynamic light 
scattering (DLS, DynaPro, Protein Solutions) measurements in pH 7.4 HEPES (6 mM 
ionic strength) and pH 11 CAPS (6 mM ionic strength) buffers in order to observe pH 
responsivity. Microgel samples in the respective buffers were equilibrated for 20 minutes, 
following which scattering intensity fluctuations based on Brownian motion of the 
microgels were detected at a scattering angle of 90⁰. 25 acquisitions of 20 seconds each 
were obtained and used to generate intensity time correlation functions. Cumulants 
analysis was then used to attain diffusion coefficients and the Stokes-Einstein equation 
was utilized to calculate the RH values. The procedure was repeated 3 more times on the 
same sample in order to generate a total of 100 RH values for each microgel sample and 
averages of these RH values along with standard deviations are presented. 
 
2.2.4 Atomic Force Microscopy  
 Atomic Force Microscopy (AFM) was performed using an MFP-3D AFM 
(Asylum Research). Images were acquired in air and under ambient conditions in the 
tapping mode, using pyramidal cantilevers (Nanoworld, Force Constant 42 N/m) made of 
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heavily doped silicon. Image processing was performed using software written in an 
IgorPro environment (Wavemetrics, Inc.). 
 Samples were prepared on 22 mm × 22 mm glass coverslips (VWR). The 
coverslips were first cleaned by sequential sonication in Alconox solution, DI water, 
acetone, 95% ethanol, and isopropanol for 20 minutes each. They were then 
functionalized in a 1% (v/v) APTMS/absolute ethanol solution on a shaker table for 2 h, 
and subsequently modified with a 0.1 mg/mL PSS solution in pH 7 phosphate buffer (50 
mM ionic strength) for 30 minutes in order to render the glass surface anionic. The 
coverslips were then washed with DI water. Microgel solutions prepared in the same 
phosphate buffer described above were then used for submonolayer deposition onto the 
glass substrates by centrifugation at 2250 × g for 15 - 20 minutes (depending on the 
microgel type)  at 25 ⁰C using a plate rotor. The coverslips were rinsed well with DI 
water and dried with nitrogen before imaging. 
 
2.2.5 CBQCA assay for quantification of amines 
 The efficiency of APMA incorporation during polymerization was determined by 
quantifying the accessible amine groups in the microgels using a fluorescence-based 
assay (Life Technologies), based on the reaction of ATTO-TAGTM CBQCA (3-(4-
carboxybenzoyl)quinoline-2-carboxaldehyde) with primary amines. A reference standard 
curve was generated using monomeric APMA solutions (sample volume = 135 µL) 
prepared in sodium borate buffer (pH 9.3, 100 mM ionic strength). The reagent solutions 
of KCN (20 mM) and ATTO-TAG
TM
 CBQCA (working solution of 5 mM concentration) 
were also prepared in the same buffer and following addition of these reagents, all sample 
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solutions (total volume = 150 µL) were incubated at room temperature with shaking for 
60-90 minutes and kept protected from light. Microgel solutions prepared in borate buffer 
were treated in an identical manner as the standards. The fluorescence of all solutions 
was then measured using a plate reader (Infinite® 200 PRO NanoQuant™, Tecan Group 
LTD., San Jose, CA) at excitation and emission wavelengths of 465 nm and 550 nm, 
respectively. After correcting these values for background from the buffer, the percent 
efficiencies of APMA incorporation in the microgels were determined. 
 
2.3 Results and discussion 
 
2.3.1 Synthesis and fundamental characterization of amine functionalized microgels 
 Cationic microgels synthesized with varying monomer molar feed ratios of 
NIPMAm:APMA and under numerous experimental conditions (Tables 2.1.1, 2.1.2, 




































at pH 11 
µgel1 1 97 2 0.50 -- 25 563±33 559±40 
µgel2 5 97 2 0.50 -- 50 436±23 419±21 
µgel3 7 91 2 0.25 -- 85 433±17 380±13 
µgel4 7 91 2 -- 4 -- 425±16 397±17 
µgel5 9 89 2 0.25 -- -- 94±2 86±3 
µgel6 9 89 2 0.25 -- 100 311±12 296±9 
µgel7 9 89 2 -- 3 -- 261±8 244±7 


























at pH 11 
µgel8 9 89 2 0.25 -- 64±2 58±1 
µgel9 9 89 2 -- 3 184±5 160±4 
[Total monomer] = 140 mM, Reaction initiation temperature = 50 °C,  





















µgel10* 0 98 2 1.0 
µgel11 1 97 2 0.5 
µgel12 5 93 2 0.5 
[Total monomer] = 50 mM, Temperature = 65 °C 
*[Total monomer] = 140 mM 
 
 
 The pH responsivity observed in low ionic strength pH 7.4 HEPES and pH 11 
CAPS buffers (pKa of APMA ≈ 10) demonstrated successful incorporation of the 
cationic comonomer APMA. Buffers of low, 6 mM ionic strength were used in order to 
reduce the effects of charge screening, thus facilitating observation of pH responsivity to 
a greater extent. The motivation behind the development of a large range of microgels 
was two-fold. Firstly, modifications in synthesis conditions generated microgels of 
different dimensions. This versatility with respect to size is a desirable quality, 
particularly for particles that have the potential to be used in different environments in 
biological systems. Secondly, the variation in APMA incorporation within the particles 
during synthesis provides tunability with regards to degree of functionality and thus 
further bioconjugation. Since it has been shown that cationic polymers can potentially be 
toxic to cells,
41
 a definitive control on the density of amine groups present in the 
microgels can also be leveraged for utilization of these constructs in biological 
environments. The interplay between the aforementioned microgel features was 
quantified by measuring the RH and amine content of the microgels. The ‘knobs’ that 
were tuned to achieve differences in microgel characteristics included monomer ratios, 
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concentration of NaCl, concentration and identity of the initiator, initiation temperature 



















Figure 2.1. AFM height traces of µgel1 to µgel12 (A to L respectively) deposited on pre-
functionalized glass by centrifugal deposition at 2250 × g for 15 - 20 minutes at 25 ⁰C, 
depending on the microgel type. Images qualitatively demonstrated monodispersity of 




 Figure 2.1 presents images of microgels obtained using atomic force microscopy. 
Owing to their deformability, microgels deposited on functionalized glass substrates are 
often seen to be flattened (~hemispherical), as illustrated by these images. Within the 
group of microgels synthesized using V50 as an initiator, an increase in NaCl 
concentration during synthesis led to an increase in particle diameter. This is indicated by 
the RH values of µgel5 and µgel6. This trend can be attributed to the screening of charges 
caused by NaCl, leading to a decrease in Coulombic repulsion between APMA-
containing polymer chains. The electrostatic repulsion when uninhibited, prevents chain 
collapse due to positioning of like positive charges along the polymer backbone. This 
leads to free polymer chains in solution and thus smaller microgel size resulting from less 
polymer incorporation in the particles.32 Additionally, the charged monomer in solution 
acts as a polymerizable surfactant and displays behavior similar to that of an ionic 
surfactant, thus further limiting the growth of particle size.
42,43
 The RH values of 
microgels µgel1, µgel2, µgel3 and µgel6 are demonstrative of this effect of NaCl 
concentration on particle size. However, above a threshold concentration, deformation of 
microgels was observed (Figure B.1.A, Appendix B). This threshold varied with 
monomer feed concentrations and its occurrence can likely be attributed to the formation 
of block copolymers at the periphery of the microgels in a charge screening environment, 
which leads to the development of particles that are not perfectly spherical.31,44 These 
artifacts in structure, while well demonstrated in the AFM images, were also revealed by 
an inconsistency in RH values obtained using DLS. This is because the Stokes-Einstein 
equation relates the diffusion coefficient D of a spherical ‘Stokes’ particle to its RH. Upon 
increasing the NaCl concentration further, macroscopic aggregation of the polymer was 
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observed, demonstrating disappearance of electrostatic stabilization in the system due to 
increased charge screening.  
 For syntheses initiated using the anionic initiator APS, microgel size increased 
with increasing concentration of the initiator. At first glance this is counterintuitive, as 
ordinarily an increase in initiator concentration would be expected to lead to a higher rate 
of nucleation than propagation, which leads to a large number of smaller particles. There 
are two possible explanations for the observation of a reverse trend in the case of these 
microgels. Firstly, proton abstraction from the carbon adjacent to the primary amine 
group in APMA, causes the generation of secondary reactive sites. This occurs due to the 
nucleophilicity of the radical center oxygen in the persulfate radical. Self crosslinking 
and larger particle size result from this phenomenon due to an increase in the efficiency 
of polymer incorporation. Hu et al. observed larger yields in cases of reactions initiated 
using APS when compared to those initiated using V50.
31
 These observations were also 
demonstrative of better polymer incorporation in the microgels. Secondly, the process of 
stabilization of microgels by positive charges contributed by APMA is hindered by the 
presence of negatively charged sulfate groups from APS. This necessitates the 
accumulation of a larger number of primary particles to generate a microgel stabilizing 
net positive charge, causing build-up of particle size. This reasoning is supported by the 
observations of Still et al. concerning positive zeta potential values obtained in syntheses 
of p(NIPAm-co-AEMA) and negative values obtained in a similar synthesis conducted in 
the absence of AEMA.
33
 Above a threshold concentration of APS, this ‘neutralization’ of 
charges leads to an effect similar to that observed with higher NaCl concentrations in 
syntheses described previously, i.e. the formation of misshapen microgels (Figure B.1.B, 
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Appendix B). Microgels were also synthesized using a different crosslinker 
Poly(ethylene glycol) (200) diacrylate (Polysciences, Inc.) or PEG-DA, and were 
designated µgelPEG. This synthesis was performed with molar feed ratios of 93:2:5 
corresponding to NIPMAm:PEG-DA:APMA and in the presence of 50 mM NaCl. These 
microgels were also analyzed for their RH via DLS and their hemispherical profile via 
AFM (Figure B.2, A), in order to demonstrate the versatility of the approach. 
 Microgels synthesized by means of a temperature ramp commencing after 
initiation (µgel8 and µgel9) were found to be smaller than their counterparts obtained via 
traditional syntheses. pNIPAm and pNIPMAm based microgels have been synthesized in 
a similar manner before,
13,45
 with initiation at a temperature lower than that used for 
conventional syntheses, followed by a gradual, steady increase in solution temperature as 
the reaction progresses. In these cases, large microgels were obtained due to a bias 
created towards particle growth through chain propagation vs. the generation of 
nucleation sites. A continuous increase in temperature during the synthesis ensures that 
the propagation rate is not sacrificed due to consumption of the monomer, by increasing 
the number of radicals generated. It is noteworthy that these ramp syntheses performed in 
the past have involved the use of an anionic comonomer. The observation of a somewhat 
reverse trend in the case of p(NIPMAm-co-APMA) microgels synthesized on a 
temperature ramp (50-70 ⁰C) via initiation with the cationic initiator V50 (µgel5 and 
µgel8) or anionic initiator APS (µgel7 and µgel9) may be attributed to the heavy 
influence of cationic comonomers on the formation of water soluble polymers during the 
synthesis. A similar phenomenon was observed by Mai-ngam et al. when analyzing the 
phase separation of p(NIPAm-co-APMA) polymers.
44
 In their experiment, 
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conformational collapse was not observed at temperatures up to 45 ⁰C in pure water, in 
spite of the LCST of pNIPAm being 31 ⁰C. This was due to strong electrostatic repulsion 
between the positively charged amine groups along the polymer chain. The addition of 
salt however, facilitated phase separation through charge screening. The same argument 
may be extended to microgel synthesis of µgel8 and µgel9, since these were conducted in 
the absence of any salt. At the temperature of initiation, Coulombic repulsion between the 
positively charged amine groups along the polymer chain dominates over the collapse of 
polymer chains. Thus, a majority of the monomer is utilized in the formation of polymer 
chains in solution. This can be observed as a temperature driven amplified effect of the 
same phenomenon discussed earlier, that leads to the generation of small microgels when 
a high feed ratio of amine containing comonomer is used. Despite the fact that the 
syntheses discussed here were initiated at a temperature higher than the ones conducted 
by Mai-ngam et al., the same reasoning may be considered applicable because of the 
higher LCST of pNIPMAm (≈ 44 ⁰C). As the temperature gradually increases, the coil to 
globule transition of the polymer begins to occur. However, by the time this stage of the 
synthesis is reached, another factor, namely the incorporation of the crosslinker BIS into 
the particles, comes into play. It has been postulated by Meunier et al. that the depletion 
of free BIS through incorporation into the polymer, acts as a deterrent towards any 
further capture of free polymers by the microgels from solution.
32
 Thus particle growth is 
further impeded. All these factors contribute to the formation of microgels smaller than 
those generated through a conventional synthesis, under similar conditions. It is 
worthwhile to note that the reactivity ratios of NIPAm and BIS are different from those 
of NIPMAm and BIS. However, the results obtained here indicate that these differences 
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may not be a major contributing factor due to the overpowering effect of the comonomer 
APMA on the syntheses. 
 
2.3.2 Quantification of primary amine incorporation in microgels during synthesis 
 Following analysis of the physical characteristics of all microgels, the ATTO-
TAG
TM
 CBQCA reagent was used  to determine the content of accessible primary amines 
on the microgels via a fluorescence based assay.
46
 This reagent is non-fluorescent by 
itself in aqueous solutions. However, it reacts with primary amines in the presence of 
cyanide to yield a fluorescent derivative, and is capable of detecting proteins in nanogram 
quantities though primary amine derivatization. Historically, the incorporation of primary 
amine functional groups during microgel synthesis has not been very efficient, as 
described above. Moreover, the low magnitude of pH responsivity, when observed for the 
microgel solutions (Table 2.1) indicated that the degree of APMA incorporation during 
the synthesis of almost all microgels was fairly low. Hence, the CBQCA assay was the 
analysis method of choice, due to its low detection limit, which should permit the 
quantitative analysis of amines even if incorporation degrees were low. A standard curve 




















Figure 2.2. Incorporation of APMA in moles, in 135 µL of 1 mg/mL solutions of the 
respective microgels (grey bars) and percent efficiency of incorporation of APMA (red 
circles) in conventional microgel populations with varying APMA feed ratios (A) and 
core/shell microgel architectures (B), analyzed via CBQCA assay (values presented as 
averages of 3 trials, error bars represent standard deviations of these three values) 
 
 
 Taking into consideration the monomer feed ratios during the syntheses, the 
efficiencies of incorporation of APMA during polymerization were calculated and are 
presented in Figure 2.2. Analysis on µgel10 solutions demonstrated fluorescence close to 
that of the background, thus indicating the absence of any interference from non-primary 
amine groups, at the concentrations under consideration. A general upward trend in the 
moles of APMA incorporated within the microgels is observed, based on the monomer 
feed ratio of APMA, in microgels µgel1 (1 mol % feed APMA), µgel2 (5 mol % feed 
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APMA) and microgels µgel3 and µgel4 (7 mol % feed APMA). For µgel5, µgel6, µgel7, 
µgel8 and µgel9, the absence of a clear trend can be attributed to the stark difference in 
RH values of these microgels compared to the others, and thus dissimilar number 
densities. With a low feed ratio of APMA in µgel1, a low amount of amine groups are 
successfully assimilated within the microgel network, but a high incorporation efficiency 
of 33% is observed. This result is in agreement with the argument put forth by Meunier et 
al., described earlier. At lower APMA feed ratios, the electrostatic repulsion between 
positively charged amine groups randomly positioned along the forming polymer chains 
is minimal and polymer collapse is not impeded. This results in higher APMA 
incorporation efficiency and larger microgels. Therefore, in spite of a lower concentration 
of NaCl being used in the synthesis, µgel1 have larger RH values (in comparison to µgel2, 
µgel3 and µgel6). As the APMA feed ratio is increased, the percent efficiency of amine 
incorporation within the microgels remains within a range from 16-23%, despite 
differences in the microgel sizes, hinting at the fact that in the syntheses, a compromise 
of microgel size is favored over that of the APMA incorporation efficiency. 
 In order to analyze variants of microgel architecture, two core/shell structures 
were synthesized using a ‘seed and feed’ method. Microgels with such architectures have 
been demonstrated to be useful for applications requiring dual functionality, such as 
loading of therapeutics in the core, and cell specific targeting through conjugation of 
relevant molecules to the shell,14 and for ratiometric imaging.47 The cores used for both 
syntheses were the same and were synthesized with no APMA (µgel10). They were 
found to have an RH value of 459 ± 24 nm in pH 7.4 HEPES buffer of 6 mM ionic 
strength. Core/shell architectures µgel11 and µgel12 were generated by depositing two 
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different shells on µgel10 with APMA feed ratios of 1 mol % and 5 mol %, respectively. 
The AFM images of the core/shell structures revealed well-defined, hemispherical 
particles (Figure 2.1 K, L). Reliable RH values could not be obtained for these microgels, 
which may be attributed to their larger size leading to a combination of non-random 
movement, i.e. sedimentation and number fluctuations due to low particle concentration 
in the DLS measurement volume. Analysis of the primary amine content of these 
microgels via the CBQCA assay revealed the moles of APMA incorporated in µgel11 
and µgel12 to be approximately an order of magnitude below their conventional microgel 
counterparts, µgel1 and µgel2 (Figure 2.2 A, B). The inclusion of APMA only in 
microgel shells is a possible explanation for this observation. However, the trend 
observed was similar, i.e. a lower feed ratio of APMA resulted in a lower number of 
moles being incorporated. The percent efficiency of APMA incorporation was found to 
be 8 ± 0.31 % and 4 ± 0.08 in % µgel11 and µgel12 respectively. This low efficiency 
may be due to a reasoning similar to that proposed by Meunier et al. as explained above, 
relating to the formation of polymer chains in solution. Additionally, the formation of 
secondary ‘core’ microgels in solution (detected via DLS on supernatants following 
ultracentrifugation) may be responsible for a further decrease in incorporation efficiency 
of APMA within the shells formed on pre-existing cores. 
 
2.4 Conclusion 
 We have successfully synthesized and characterized a large range of cationic 
microgels with varying amounts of primary amine groups incorporated within the 
polymer networks. These microgels have potential applications in bioconjugation 
reactions. The syntheses were optimized to generate monodisperse, stable microgels and 
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the particles were analyzed in detail with the goal of generating information about the 
incorporation efficiency of the amine containing comonomer. Furthermore, the effects of 
various synthesis conditions on microgel size and APMA incorporation efficiency were 
also investigated. All these studies have helped in the establishment of a toolbox of amine 
functionalized microgels, with constructs being suited to a wide range of applications. In 
particular, these investigations have revealed previously unknown aspects of these 
systems, with extensive studies providing corroboration through trends observed in 
microgel behaviors. Due to the large number of possible reactions with primary amines, 
the opportunities of conjugations to these microgels are boundless, with ample flexibility 
available for a vast array of systems. These particles thus have prospective utility in a 
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MICROGEL-DYE CONJUGATES AS VIABLE CANDIDATES FOR 
THE GENERATION OF HIGH INTENSITY PHOTOACOUSTIC 
SIGNALS 
 
Portions of this to be included in submission to Journal of Materials Chemistry B 
 
3.1 Introduction 
 In Chapter 2, we developed a range of amine functionalized microgels and 
characterized them with respect to their sizes and amine incorporation during synthesis. 
These studies provided information on the effects of various synthesis conditions on 
microgel stability, size and functional group incorporation. On the basis of these studies, 
a model microgel system was used for further characterization with respect to molecular 
weight and number density. Two different dyes, malachite green and rose bengal were 
then conjugated to this microgel system, in order to demonstrate availability of the 
primary amine groups for conjugation reactions. These dyes were selected because their 
optical properties make them suitable candidates for photoacoustic imaging.
1,2
 We found 
that the local concentrations of these dyes were nearly three orders of magnitude above 
their overall concentration in solution, demonstrating the merit of using microgels as the 
conjugation scaffolds that enable the local concentration of active agents. The viability of 
NIH3T3 fibroblasts in the presence of these microgel-dye constructs was also studied. 
This investigation was carried out particularly to address the toxicity of polycations, 




 Through qualitative analysis via imaging, the microgel-dye constructs were 
found to be less toxic to cells compared to the primary amine functionalized microgels 
containing no dye, presumably due to consumption of amine groups during conjugation, 
which is a promising outcome for their utilization in conjunction with biological systems. 
 
3.2 Experimental section 
 
3.2.1 Materials 
 For information on common materials, refer to Chapter 2, section 2.2.1. Buffer 
preparation materials 2-(cyclohexylamino)ethanesulfonic acid (CHES) and 4-
Morpholineethanesulfonic acid (MES), dyes malachite green isothiocyanate (MGITC, 
Life Technologies) and rose bengal (RB), coupling reagents N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysulfosuccinimide sodium salt 
(NHSS), calcium nitrate, 1X PBS (phosphate buffered saline, Corning Cellgro), 
Dulbecco's Modified Eagle Medium (DMEM, Corning Cellgro), methanol, dimethyl 
sulfoxide (DMSO) and dyes from the live/dead cytotoxicity kit (Life Technologies) 
calcein AM and ethidium homodimer-1 (EthD-1) were all used as received. 
 
3.2.2 Microgel synthesis 
 Microgels were synthesized using a procedure similar to that utilized for µgel2, 




3.2.3 Dynamic Light Scattering 
 RH values for microgels were obtained in a manner identical to that described in 
Chapter 2, section 2.2.3  
 
3.2.4 Atomic Force Microscopy 
 AFM images of microgels deposited on pre-functionalized glass substrates were 
obtained usng a procedure similar to that described in Chapter 2, section 2.2.4. 
 
3.2.5 CBQCA assay for quantification of amines 
 The incorporation of amine groups in microgel matrices during synthesis was 
quantified using the CBQCA assay, in a manner identical to that described in Chapter 2, 
section 2.2.5. 
 
3.2.6 Tunable resistive pulse sensing  
 The qNano (IZON Science, Oxford, UK) was utilized for performing resistive 
pulse sensing via examination of translocation events of particles through a tunable 
polyurethane nanopore (IZON Science Ltd. NZ) NP400, which is suitable for analysis of 
particles with diameters between 200 and 800 nm. HEPES buffer (pH 7, 150 mM ionic 
strength) was first introduced in the cells on both sides of the nanopore, in order to 
generate a stable baseline current. Following this, the buffer in the cell above the 
nanopore was replaced with 40 µL of the relevant sample solution. All microgel solutions 
were used at a concentration of 0.2 mg/mL, and the measurements were standardized 




 particles/mL and a mean diameter of 350 nm, by performing sample 
and standard measurements under identical conditions of voltage, nanopore stretch and 
pressure. The proprietary software provided by Izon was utilized for sample and data 
analysis. Three sets of measurements generated a total of ~ 215 values for RqNano for each 
sample. The RqNano distribution from these values is presented. The three sets also 
provided three values of microgel number density per sample. The averages and standard 
deviations of these values are presented. 
 
3.2.7 Conjugation of dyes to microgels  
 Malachite green: The lyophilized microgels were weighed and resuspended 
overnight in pH 9.8 CHES buffer (pH 9.8, 20 mM ionic strength) to a concentration of ~ 
3 - 5 mg/mL. Following this, MGITC dissolved in DMSO was added to the microgel 
solution in a 4.5X molar excess based on the amount of amine groups in the microgels. 
The conjugation reaction was allowed to proceed overnight at 4 ⁰C on a shaker after 
which the solution was dialyzed against DI water for 2 – 4 weeks at 4 ⁰C in order to get 
rid of excess dye and buffer. 
 Rose bengal: For conjugation to RB, the lyophilized microgels were weighed and 
resuspended in phosphate buffer (pH 7, 50 mM ionic strength) to a concentration of ~ 2 – 
4 mg/mL. The dye was then conjugated to the microgels by dissolving it in the same 
buffer and adding it to the microgel solution in a 4X molar excess (for µgel1-RB, µgel2-
RB and µgel6-RB) or a 10.5X molar excess (for µgel2b-RB) based on the concentration 
of amines. EDC and NHSS were also used in the same molar excess as RB, for the 
respective conjugations. The reaction was allowed to proceed overnight at room 
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temperature on a shaker, after which the solution was dialyzed against CAPS (pH 11, 500 
mM ionic strength) for 3 - 5 weeks to remove excess dye and then against DI water for 2 
- 3 weeks to remove buffer components.  
 The dialyzed dye conjugated microgel solutions were left on a shaker overnight in 
order to ensure homogeneity after which small portions of the solutions were lyophilized 
to determine the concentration of the ‘stock’ solutions. 
 
3.2.8 Absorbance measurements  
 The dye conjugated microgel solutions of known concentrations were analyzed 
for dye content via absorbance measurements done in a plate reader (Infinite® 200 PRO 
NanoQuant™, Tecan Group LTD., San Jose, CA). Standard curves were generated by 
using dye solutions of MGITC (stock solution in DMSO, remaining dilutions in DI 
water) and RB (in water). Upon determining the λmax values (625 nm for MGITC and 540 
nm for Rose Bengal), absorbance measurements were performed at the corresponding 
wavelengths. Absorbance values of the dye conjugated microgels were then determined 
at these wavelengths, after ensuring that scattering by microgels was not causing 
perturbation of the obtained results and the moles of dye conjugated, and conjugation 
efficiencies were calculated. 
 
3.2.9 Cell culture  
 NIH3T3 cells were grown in DMEM (supplemented with 10% Fetal Bovine 
Serum and 1% penicillin streptomycin) on T75 flasks until they were 80% confluent. The 
medium was then removed from the flask, after which the cells were split through 
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treatment with 5 mL trypsin/EDTA (0.25%) followed by a 5 min incubation at 37 ⁰C. 
The cell count was then determined using a hemocytometer (Reichert Bright Line), and 
then pelleted down by centrifugation at 1200 × g for 5 minutes. The supernatant was 
aspirated out and the cells were resuspended in medium to a concentration of 1 million 
cells/mL. The cells were further diluted using medium and plated to a concentration of 
10000 cells/cm
2
 in a 96 well plate and allowed to spread on the surface for 3 - 4 h. 
Following this, the medium was removed via aspiration and the microgel solutions 
diluted in medium were added to the corresponding wells. A change of medium was 
made for the control wells to maintain uniformity in procedure. The well plate was then 
incubated for 24 h at 37 ⁰C and the live dead assay was performed on the cells. 
 
3.2.10 Viability studies  
 The live/dead assay protocol (Life Technologies) was performed in a sterile tissue 
culture hood. The medium was aspirated from the sample wells and controls and the 
wells were washed gently with 200 µL 1X PBS. The cells in the dead control wells were 
then killed by incubating them with 100 µL of 70% methanol for 30 minutes. 100 µL 1X 
PBS was added to the remaining wells for the same period of time. The methanol and 1X 
PBS were then removed gently with a pipette, following which single or both dye 
solutions (Calcein AM and EthD-1) were added to the corresponding wells with controls 
and samples. The 96 well plate was subsequently incubated at room temperature for 45 
min and protected from light. The solutions from all wells were then gently removed 
using a pipette and all wells were washed gently with 200 µL 1X PBS, following which a 
4% v/v formaldehyde/1X PBS solution was introduced into the wells for the purpose of 
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fixing the cells. After an incubation of 15 minutes, the formaldehyde was pipetted out and 
all wells were gently washed twice with 200 µL 1X PBS. 100 µL 1X PBS was added to 
all the wells before conducting fluorescence measurements. The excitation and emission 
wavelengths of Calcein, 528 nm and 645 nm respectively, were utilized for the 
measurements and the percent viability values of the cells were calculated. 
 
3.2.11 Confocal microscopy  
 The samples were prepared in a sterile tissue culture hood. Round coverslips (12 
mm diameter, 0.17-0.25 mm thickness, Electron Microscopy Sciences) were immersed in 
70% ethanol for 30 minutes, after which they were dried and introduced into a 24 well 
plate. They were incubated in DMEM for 1 h at 37 ⁰C in order to facilitate cell 
attachment. The cells were then plated at a concentration of 10000 cells/cm
2
 in each well 
and were allowed to spread for 3 - 4 h. Following this, a similar procedure as the one for 
the 96 well plate was used for incubation with microgels and staining of the cells, with 
volume adjustments. The coverslips were then air dried and preserved in ProLong® Gold 
Antifade reagent (Life Technologies). The samples were sealed with nail polish and kept 
protected from light, at 4 ⁰C until they were imaged. 
 Images were obtained on a Confocal Laser Scanning Microscopy (CLSM, Zeiss 
LSM 700) by setting the pinhole diameter to 1 airy unit. Image processing was performed 





3.2.12 Generation of photoacoustic signals using microgel-dye conjugates 
 Photoacoustic signal generation was performed by Aida Demissie, from the 
Dickson research group at Georgia Tech. Tissue phantoms with optical properties similar 
to those of human skin tissue, were made using sodium alginate Protanal LF 10/60 (FMC 
Biopolymer, Drammen, Norway) and cross-linked in an 80 mM solution of calcium 
nitrate. Solutions of microgel dye conjugates (1 mg/mL for µgel 2a-MGITC and 2 
mg/mL for µgel 2a-RB) were added to the alginate solution prior to crosslinking and then 
placed in the calcium nitrate solution for 30 minutes.
 
 Photoacoustic signals from phantoms were measured on an inverted microscope 
(IX70-S1F2, Olympus) through a 40X dry objective. In order to generate signals, a 
pulsed laser was used to satisfy both thermal and stress relaxation time conditions. 
Photoacoustic signals were generated by a pulsed primary laser (532 nm, 10 kHz 
repetition) and were detected by a broadband submersible piezoelectric transducer with 
central frequency 10MHz (U8427003, Olympus NDT Inc, USA). Signals were amplified 
with a broadband amplifier (U8120004, Olympus NDT Inc, USA) and recorded on an 
oscilloscope (TDS5104B, Tektronix) 
 
3.3 Results and discussion 
 In chapter 3, we demonstrated the development and characterization of several 
amine functionalized microgels. Based on the microgel sizes, profiles and primary amine 
contents , µgel2 was selected as a model system for further characterization and 
conjugations. The reasons behind this selection were multi-fold. Firstly, the content of 
primary amine groups in these microgels was intermediate in the range of microgels 
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studied. This content measured via the CBQCA assay was corroborated with the help of a 
second technique, pH titrations (Figure B.3, Appendix B). The comparative results from 
both these analysis methods are presented in Table 3.1. The agreement in these values 
demonstrated the quantitative accuracy of the CBQCA assay. 
 
 
Table 3.1 Comparative values of percentage efficiency of primary amine incorporation 
during microgel synthesis using two different techniques (data from µgel2) 
 
Method used for primary amine 
quantification 
Calculated % efficiency of primary 
amine incorporation 
CBQCA assay 22 ± 2 
pH titrations 20 ± 2 
Values presented as averages of 3 trials 
 
 
 Another reason why µgel2 were selected as a model system, was because of their 
convenient size for analysis and imaging, reproducibility of synthesis, and good amine 
incorporation.  
 
3.3.1 Synthesis and detailed characterization of µgel2a and µgel2b 
 Two batches of the model system µgel2, described in Chapter 2, were 
synthesized, µgel2a and µgel2b (feed ratios of NIPMAm:BIS:APMA :: 93:2:5). Their RH 
values in pH 7.4 HEPES and pH 11 CAPS buffers were found to be 413 ± 29 nm and 377 
± 24 nm for µgel2a and 409 ± 19 nm and 387 ± 15 nm for µgel2b respectively. The 














Figure 3.1. AFM height traces of µgel2a (A), µgel2a-MGITC (B), µgel2b (C) and 
µgel2b-RB (D) deposited on APTMS-functionalized glass by centrifugal deposition at 
2250 × g for 15 minutes at 25 ⁰C. Images qualitatively demonstrated monodispersity of 
individual microgel suspensions. Solutions of µgel2a-MGITC and µgel2b-RB and dried 
microgel samples are shown adjacent to the corresponding images 
  
 
 The microgels were also observed via AFM imaging following centrifugal 
deposition on pre-functionalized glass. They were found to be monodisperse with a 
spherical profile (Figure 3.1 A, C).  
 To determine the physical radii of individual microgels and number densities of 
microgel solutions, dispersions of both µgel2a and µgel2b were subjected to tunable 
resistive pulse sensing in a high ionic strength buffer. This technique based on the 
Coulter principle detects passage of single particles through a nanopore. A decrease in the 
 66
intensity of current whenever a particle passes through the pore, detected as a blockade 
event, provides information about the population density of the dispersion and properties 
of individual particles. The distributions of microgel radii as obtained by this method are 















Figure 3.2. Particle size distribution of dispersions of µgel2a (A) and µgel2b (B) as 
determined through tunable resistive pulse sensing (each graph represents a distribution 
of ~ 215 RqNano values obtained through a total of 3 trials) and a schematic demonstrating 




 All measurements were calibrated against standard solutions of polystyrene beads 
of relevant dimensions and values were obtained as averages from three sets of 
measurements on the qNano. When compared to the hydrodynamic diameters (DH) of the 
microgels in similar conditions of ionic strength, the diameters obtained via the qNano 




Table 3.2 Population characteristics of µgel2a and µgel2b with comparative microgel 
sizes obtained via tunable resistive pulse sensing using the qNano and hydrodynamic 








DqNano (nm) DH (nm) 
µgel2a (7.83 ± 2.42)×10
9
 (8.31± 3.04)×1010 499 ± 114 764 ± 42 
µgel2b (1.30 ± 6.90)×1010 (5.39 ± 2.19)×1010 461 ± 103 746 ± 32 
Values presented as averages of 3 sets of trials 
All measurements performed in HEPES buffer (pH 7, 150 mM ionic strength) 
 
 
 This difference in measured microgel dimensions can be attributed to the fact that 
the RH measured by dynamic light scattering takes into account the dangling polymer 
chains around the microgels and hence tends to be an overestimation of the microgel 
radius when compared to the physical size. Furthermore, since resistive pulse analysis 
involves standardization against hard spheres, it does not take into account the volume of 
buffer within the porous microgels, which is responsible for making them conductive. 
Thus, when examined in parallel to the resistive pulse due to a hard sphere, that observed 
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for a comparable microgel is of lower magnitude due to its buffer content and therefore, 
its volume is underestimated, leading to a further discrepancy in size. Based on the 
number density obtained via the qNano and the weight percent of the starting microgel 
solutions, the molecular weights of µgel2a and µgel2b were found to be (8.31± 
3.04)×1010 g/mol and (5.39 ± 2.19)×1010 g/mol respectively (Table 3.2). 
 Further analysis of µgel2a and µgel2b with respect to their primary amine content 




 A standard curve was 
generated using APMA solutions in pH 9.3 borate buffer and the efficiency of APMA 
incorporation in the microgels was found to be 25 ± 3 % for µgel2a and 20 ± 2 % for 
µgel2b. The average number of moles of APMA in the microgels were found to be (1.27 
± 0.16)×10-8 and (1.05 ± 0.11)×10-8 respectively. 
 
3.3.2 Conjugation of dyes to microgels and characterization of microgel-dye 
constructs 
 Following characterization of the cationic microgels, two dyes, malachite green 
and rose bengal were conjugated to µgel2a and µgel2b respectively. The conjugations 
were performed via the amine groups in the polymer matrices, using different techniques. 
This study was performed to determine the applicability of these microgels as agents of 
conjugation through a demonstration of the accessibility of their primary amines for 
covalent conjugations. Malachite green (MG) was conjugated in the form of its derivative 
MGITC (4.5X molar excess) in a manner similar to that utilized by Nayak et al.
5
 RB was 
conjugated in its native form by carbodiimide coupling using EDC in the presence of 
NHSS (10.5X molar excess of reagents used) (Scheme B.2, Appendix B). The two 
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conjugates thus obtained, µgel2a-MGITC and µgel2b-RB have potential applications in 
bioimaging through techniques like photoacoustic and fluorescence imaging.
1,6
 The 
conjugations were followed by purification through dialysis. µgel2a-MGITC was 
dialyzed against DI water, while µgel2b-RB was subjected to a two step dialysis method 
due to the non-specific interactions between free dye and the microgels. The first step 
involved dialyzing the microgel-dye conjugate solution against pH 11 CAPS buffer of 
very high ionic strength (500 mM). This buffer served the purpose of decreasing 
Coulombic interactions between the two species through the deprotonation of the amine 
groups on the microgels and by decreasing the Debye screening length of the charged 
species. Following this first step of dialysis, the second step involved dialysis against DI 
water to facilitate replacement of the buffer. 
 
 
Table 3.3 Concentrations of conjugated dyes (MGITC and RB) per microgel in 
comparison to dye concentration in solution and efficiency of conjugation reactions 




concentration of dye 
in solution (mM) 
Concentration of 
dye/microgel   
(mM) 
% Efficiency of 
dye conjugation 
µgel2a-MGITC 0.035 ± 0.010 20.88 ± 7.66 42.50 ± 11.50 
µgel2b-RB 0.034 ± 0.001 13.99 ± 5.67 46.41 ± 2.61 
Values presented as averages of measurements on two sample dilutions 
 
 
 After purification, µgel2a-MGITC and µgel2b-RB were analyzed for their 
hydrodynamic radii by DLS in low ionic strength buffers. The results obtained are 
 70
summarized in Table 3.3. The pH responsivity of µgel2a-MGITC can be attributed 
partially to the free amine groups remaining post conjugation. Additionally, it may also 
be ascribed to the pKa of malachite green being 6.9,
7
 leading to the presence of the 
charged dye species R=N(CH3)2
+ at pH 7.4. RH measurements performed on µgel2b-RB 
in pH 11 CAPS buffer did not yield reliable results, which may be due to aggregate 
formation through charge screening at the higher pH, leading to enhanced hydrophobic 
interactions. AFM on µgel2a-MGITC and µgel2b-RB following deposition on 
functionalized glass demonstrated no distortion in the hemispherical profile of the 
microgels post dye conjugation (Figure 3.1 B, D). 
 In order to determine the conjugation efficiencies of MGITC and RB, absorbance 
measurements were performed. For these, the concentrations of microgel-dye constructs 
used were low enough to prevent interference due to scattering from the colloidal 
microgel particles. Measurements were done on µgel2a-MGITC and µgel2b-RB solutions 
alongside standard absorbance curves prepared using MGITC and RB solutions, at λmax 
values of 625 nm and 540 nm respectively (Figure B.4, Appendix B). These revealed 
that the dye concentrations of the stock 1 mg/mL microgel solutions were 0.035 ± 0.010 
mM and 0.034 ± 0.001 mM respectively. For comparison, µgel1, µgel2 and µgel6 (AFM 
height traces in Figure S6, Supporting Information) from the original series described in 
Chapter 2, were also conjugated to RB, but with a lower molar excess of the conjugation 
agents (4X). The motivation behind the synthesis of these microgels was to demonstrate 
the trend in primary amine group availability for reactions in two ways. First, through the 
conjugation of RB to microgels with different starting amounts of amines (µgel1-RB, 
µgel2-RB and µgel6-RB) and second, through the analysis of microgels with the same 
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starting density of amines but varying amounts of reagents used for conjugations (µgel2-
RB and µgel2b-RB). The results obtained from absorbance measurements are presented 













Figure 3.3. Microgel-RB conjugates analyzed for dye content via absorbance 
measurements at λmax = 540 nm. Bars with dashed pattern represent conjugates µgel1-RB, 
µgel2-RB and µgel6-RB generated using low ratios of conjugation reagents. The brick 
pattern represents µgel2b-RB with primary amine content identical to µgel2-RB, but 
conjugated to RB using higher concentrations of conjugation reagents. Red diamonds 
represent percent efficiencies of RB conjugations to microgels (Values presented as 
averages of measurements on two different dilutions, error bars represent standard 
deviations of these two values) 
 
 
 A similar trend as that observed for APMA incorporation (refer to Chapter 2, 
Figure 2.2) was seen for µgel1-RB, µgel2-RB and µgel6-RB. The percent efficiency of 
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conjugation was found to decrease with an increase in the number of APMA units in the 
microgels, which may be a result of differences in accessibility, particularly due to 
differences in microgel RH values and thus surface presentation of functional groups. 
Additionally, µgel2-RB and µgel2b-RB showed differences in RB conjugation amounts 
as expected, due to differences in reaction equilibria. Consequently, the efficiency of 
conjugation was also seen to be higher in µgel2b-RB, synthesized with a larger starting 
concentration of the reagents. 
 When considering utility in an imaging application like photoacoustics, the dye 
content in a specific, concentrated volume is a more relevant parameter than the overall 
dye concentration in solution. This is because in photoacoustic imaging, signals are 
generated by irradiation of a region of the sample with very small dimensions (~ 1 µm 
diameter), defined either by a point source such as a highly focused laser beam or by 
excitation of a small ~ 1 µm sized contrast agent. Thus, the concentration of dye per 
microgel was determined from the absorbance measurements using Beer-Lambert’s law, 
the molecular weights of the microgels determined previously using the qNano (Table 
3.2) and the volume of the microgels, which was calculated from their hydrodynamic 
radii. The dye concentration per microgel were found to be 20.88 ± 7.66 mM for µgel2a-
MGITC and 13.99 ± 5.67 mM for µgel2b-RB, which were almost three orders of 
magnitude above the ‘overall’ solution concentrations for the microgel dispersions. Based 
on these values and the efficiency of APMA incorporation obtained via the CBQCA 
assay, the efficiency of dye conjugation was found to be 42.50 ± 11.50 % for µgel2a-
MGITC and 46.41 ± 2.61% for µgel2b-RB. These efficiencies observed were similar in 
spite of different conjugative approaches and molar excesses of reagents being used for 
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both dyes. This may be partially due to the inherent reaction efficiencies of the  
conjugation reactions utilized, but the accessibility of the amine groups in the microgels 
may also be a major contributing factor in determining the number of dye molecules 
attached per microgel. 
 
3.3.3 Viability studies with NIH3T3 fibroblasts 
 The development of new constructs for use in conjunction with biological systems 
brings with it the necessity to examine their potential toxic effects on cells. A viability 
assay was performed using NIH3T3 fibroblasts. These particular cells were utilized 
because they have been studied extensively as model systems for analysis of cell function 
in regards to adhesion, movement, and proliferation. They have also often been used to 
































Figure 3.4. CLSM images of NIH3T3 fibroblasts incubated with varying microgel 
conjugates and concentrations for 24 h, and then stained using Calcein AM (green, live 
cell stain) and EthD-1 (red, dead cell stain) for determination of viability. Cells grown at 
a concentration of 10000 cells/cm
2
 were incubated with 0.125 mg/mL µgel2a-MGITC 
(A), 0.25 mg/mL µgel2a-MGITC (B), 0.5 mg/mL µgel2a-MGITC (C), 0.125 mg/mL 
µgel2b-RB (D), 0.25 mg/mL µgel2b-RB (E), 0.5 mg/mL µgel2b-RB (F), 0.125 mg/mL 
µgel2b (G), 0.25 mg/mL µgel2b (H) and 0.5 mg/mL µgel2b (I). ‘All live’ and ‘all dead’ 
controls (J and K) shown for comparison 
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 In the current study, NIH3T3 fibroblasts were grown on a multi-well plate at a 
uniform density of 10000 cells/cm
2
 and were allowed to adhere and spread, after which 
they were incubated with the relevant microgels for 24 hours. The microgel solutions 
were subsequently removed from the wells and the cells were stained with Calcein AM 
and EthD-1 homodimer to determine viability. The measurements performed at λex = 528 
nm  and λem = 645 nm for Calcein AM were normalized against ‘all live’ and ‘all dead’ 
cell controls and the percent viabilities were obtained (Figure B.6, Appendix B). Images 
of cells obtained via confocal microscopy following staining with the dyes, are presented 
in Figure 3.4. These images demonstrated red fluorescence from all microgels that had 
been incubated with µgel2b-RB (Figure 3.4 D, E, F). A closer examination of the images 
revealed that this red fluorescence was emanating from the cytoplasm of the cell and not 
from the nucleus. Since EthD-1 is known to stain the nucleus of dead cells (Figure 3.4 
K), this observation along with the high Calcein fluorescence exhibited by these cells 
suggested that the cells were ‘live’ and that the red fluorescence was emanating from the 
RB in µgel2b-RB particles within the cells, rather than the membrane penetrating EthD-
1. Therefore, we concluded that the microgels had been engulfed by the cells during the 
incubation period. This observation could be validated only with the µgel2b-RB particles, 
because the unconjugated cationic microgels µgel2b are non-fluorescent and the µgel2a-
MGITC particles are conjugated to MG, which has a very low quantum yield and is 
hence virtually non-fluorescent. We hypothesize that both these species of microgels had 
been engulfed by the fibroblasts as well. In the interest of avoiding any interference from 
engulfed µgel2-RB particles, all viability calculations were performed based only on 
fluorescence intensities obtained from Calcein AM. 
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 A statistical examination via one way ANOVA analysis rendered the quantitative 
viability results inconclusive, presumably due to variability in cell cultures (Figure B.6, 
Appendix B). However, the assay revealed low viability when the cells were incubated 
with the unconjugated, cationic microgels. This is not unexpected since polycations are 
known to be cytotoxic, as mentioned earlier. Qualitatively, via imaging, this cytotoxicity 
was seen to escalate with increasing concentrations of these microgel solutions incubated 
with the cells. However, when incubated with dye-conjugated microgels, the images of 
the fibroblasts obtained hinted at the comparative lower toxicity of these constructs, 
especially at lower concentrations. At higher concentrations of the microgel-dye 
conjugates, the results indicated that the microgels might be toxic to the cells, which may 
be due to the ability of the dyes to generate biologically harmful reactive oxygen species 
in solution.10,11 However, in spite of its toxicity, RB has been used in biological systems 
in the past.
12
 At the lowest concentration of the µgel-dye conjugates (0.125 mg/mL) used 
for these viability studies, low cytotoxicity was observed. This was encouraging, since 
the local concentrations of the dyes were very high as described in the earlier section. 
Thus, decreasing weight percent during introduction into a biological system may be 
feasible, in order to improve cell viability further. If the microgel-dye constructs need to 
be utilized at concentrations higher than 0.125 mg/mL, microgels synthesized from 
biocompatible materials like polyethylene glycol (PEG)13,14  may present lower toxicity to 
the cells and thus may be the material of choice moving forward. Additionally, dyes that 




3.3.4 Generation of photoacoustic signals from microgel-dye constructs 
 Both microgel-dye constructs, µgel2a-MGITC and  µgel2b-RB were incorporated 
into tissue phantoms and attempts were made to generate photoacoustic signals (Figure 
B.7, Appendix B). These signals were not reproducible, presumably due to background 
interference. Therefore, the signals represented in Figure B.7 are not reliable, warranting 




 Controlled bioconjugation reactions can be performed using well characterized 
amine functionalized microgels, as demonstrated through conjugation to the two different 
dyes utilized in this study. Absorbance measurements provided information about the 
availability of functional groups for conjugation. Local concentrations of the dyes 
calculated through analysis of the molecular weights of the microgels were found to be 
almost three orders of magnitude higher than the concentration of dye in solution. This 
was very promising for applications like photoacoustic imaging, for the generation of 
high intensity signals. This high local concentration of the conjugated entity may also be 
useful for phenomena requiring multivalency for efficient targeting in biological systems. 
Additionally, it may be beneficial for heightened interactions with biological materials 
leading to events such as clot contraction, such as that observed by Brown et al. when 
they developed artificial platelets.
15
 Viability studies conducted with NIH3T3 fibroblasts 
indicated that microgel-dye conjugates were not toxic to cells, especially when 





(1) Indig, G. L.; Jay, D. G.; Grabowski, J. J.: The efficiency of malachite green, free 
and protein bound, as a photon-to-heat converter. Biophys. J. 1992, 61, 631-8. 
 
(2) Richards, C. I.; Hsiang, J. C.; Dickson, R. M.: Synchronously Amplified 
Fluorescence Image Recovery (SAFIRe). J. Phys. Chem. B 2010, 114, 660-665. 
 
(3) Fischer, D.; Li, Y. X.; Ahlemeyer, B.; Krieglstein, J.; Kissel, T.: In vitro 
cytotoxicity testing of polycations: influence of polymer structure on cell viability and 
hemolysis. Biomaterials 2003, 24, 1121-1131. 
 
(4) You, W. W.; Haugland, R. P.; Ryan, D. K.; Haugland, N. P.: 3-(4-
carboxybenzoyl)quinoline-2-carboxaldehyde, a reagent with broad dynamic range for the 
assay of proteins and lipoproteins in solution. Anal. Biochem. 1997, 244, 277-282. 
  
(5) Nayak, S.; Lyon, L. A.: Photoinduced phase transitions in poly(N-
isopropylacrylamide) microgels. Chemistry of Materials 2004, 16, 2623-2627. 
  
(6) Serafini, A. N.; Smoak, W. M.; Hupf, H. B.; Beaver, J. E.; Holder, J.; Gilson, A. 
J.: Iodine-123-Rose bengal: An improved hepatobiliary imaging agent. J Nucl Med 1975, 
16, 629-32. 
  
(7) Nguyen, M. C.; Shoji, I.; Noboru, K.: Donnan Electric Potential Dependence of 
Intraparticle Diffusion of Malachite Green in Single Cation Exchange Resin Particles: A 
Laser Trapping-Microspectroscopy Study. American Journal of Analytical Chemistry 
2012, 2012. 
  
(8) Drescher, D.; Orts-Gil, G.; Laube, G.; Natte, K.; Veh, R. W.; Oesterle, W.; 
Kneipp, J.: Toxicity of amorphous silica nanoparticles on eukaryotic cell model is 
determined by particle agglomeration and serum protein adsorption effects. Anal. 
Bioanal. Chem. 2011, 400, 1367-1373. 
 
 79
(9) Fletcher, D. A.; Mullins, D.: Cell mechanics and the cytoskeleton. Nature 2010, 
463, 485-492. 
  
(10) Dhamgaye, S.; Devaux, F.; Manoharlal, R.; Vandeputte, P.; Shah, A. H.; Singh, 
A.; Blugeon, C.; Sanglard, D.; Prasad, R.: In Vitro Effect of Malachite Green on Candida 
albicans Involves Multiple Pathways and Transcriptional Regulators UPC2 and STP2. 
Antimicrob. Agents Chemother. 2012, 56, 495-506. 
  
(11) Lambert, C.; Sarna, T.; Truscott, T. G.: Rose-bengal radicals and their reactivity. 
J. Chem. Soc.-Faraday Trans. 1990, 86, 3879-3882. 
  
(12) Savini, G.; Prabhawasat, P.; Kojima, T.; Grueterich, M.; Espana, E.; Goto, E.: The 
challenge of dry eye diagnosis. Clin Ophthalmol 2008, 2, 31-55. 
  
(13) Lutz, J. F.: Thermo-Switchable Materials Prepared Using the OEGMA-Platform. 
Adv. Mater. 2011, 23, 2237-2243. 
  
(14) Hu, Z. B.; Cai, T.; Chi, C. L.: Thermoresponsive oligo(ethylene glycol)-
methacrylate- based polymers and microgels. Soft Matter 2010, 6, 2115-2123. 
  
(15) Brown, A. C.; Stabenfeldt, S. E.; Ahn, B.; Hannan, R. T.; Dhada, K. S.; Herman, 
E. S.; Stefanelli, V.; Guzzetta, N.; Alexeev, A.; Lam, W. A.; Lyon, L. A.; Barker, T. H.: 





MICROGEL CORE/SHELL ARCHITECTURES AS TARGETED 
AGENTS FOR THROMBOLYSIS 
 
(Purva Kodlekere, L. Andrew Lyon; Microgel core/shell architectures as targeted agents 
for thrombolysis) 
To be submitted to: Biomaterials 
 
4.1 Introduction 
 Fibrin is a biopolymer that plays a vital role in hemostasis. In the occurrence of an 
injury, fibrinogen, its soluble precursor, gets converted to insoluble fibrin through the 
action of the proteolytic enzyme, thrombin. On activation, thrombin cleaves 
fibrinopeptides in the central domain of fibrinogen. This exposes knobs that are 
complementary to holes that are always exposed, present at the distal domains of the 
molecule. The intermolecular interactions between the knobs and holes result in the 
formation of a half-staggered structure and this in turn leads to the formation of a 
protofibril. On reaching a particular length, the protofibrils aggregate laterally, leading to 
the formation of fibers. The last step involves covalent ligation by the action of activated 
factor XIII.1  
Dissolution of fibrin clots in the body is carried out by the fibrinolytic system, 
which primarily functions through the action of plasmin on fibrin clots, following 
activation of its precursor plasminogen. A delicate balance between the formation of clots 
and their dissolution is extremely crucial for maintaining normal bodily function. An 
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imbalance can either cause massive hemorrhages or the generation of thrombi, that can 
block the flow of blood through vessels. The latter leads to physiological diseased states 
such as deep vein thrombosis, atherosclerosis and stroke. In order to dissolve abnormal 
thrombi, plasminogen activators such as streptokinase, urokinase and tissue-type 
plasminogen activator (tPA) are commonly used, but direct intravenous administration of 
these agents can cause off target effects and lead to massive hemorrhages.
2
 In order to 
increase efficacy of these agents and reduce off-target effects, a number of delivery 
agents have been developed. For example, Wang et al. synthesized magnetic mesoporous 
silica nanoparticles or M-MSNs for magnetically guided, targeted delivery of urokinase 
to thrombi.
3
 McCarthy et al. utilized specific targeting to activated factor XIII, by 
conjugating crosslinked dextran coated iron oxide nanoparticles to peptide affinity 
ligands, for the delivery of tPA.4 Similarly, Absar et al. utilized peptide-grafted liposomes 
for targeted delivery of tPA to thrombi.
5
 
 Microgels form an important class of materials that have been utilized for targeted 
delivery of therapeutics in the past.
6-8
 They are colloidally stable, solvent swollen 
polymer-based hydrogel microparticles that demonstrate tremendous versatility in 
synthesis. This can be leveraged to the generation of microgels of different sizes, 
architectures and with responsivity to different stimuli such as temperature and pH.
9-11
 
Core/shell microgels have been synthesized before12-14 and provide the advantage of 
localizing functionalities and hence potential targeting agents on their surface. 





 and use the resulting system for targeted delivery. 
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 The incorporation of colloidal particles such as microgels in matrices of 
polymeric scaffolds provides the opportunity to tune properties of the matrix.
17
 Such 
modular systems are thus gaining increasing importance. The interactions of colloidal 
particles with pre-formed fibrin clots have also been studied before.18,19 Additionally, 
colloids have also been employed to generate imaging agents targeted to fibrin.20,21 The 
knowledge that fibrin clots behave as equilibrium polymers,
22
 with monomers or 
oligomers associating and/or dissociating from pre-formed fibers, has provided 
opportunities for remodeling of the structural components of fibrin. Radical-generating 
nanoparticles have therefore, also been used to bring about remodeling of fibrin without 
the help of enzymes.
23
 
 Herein, we present the development of core/shell microgels in three different size 
ranges, to be used in fibrinolysis. Investigations have been carried out with regards to 
their pH responsivity in buffers of two different ionic strengths to demonstrate the 
incorporation of AAc moieties in the microgel shells during synthesis. Atomic force 
microscopy was employed to examine the profile of these particles. The microgel 
solutions were then allowed to flow through fibrin clots, in order to examine the interplay 
between their dimensions, their deformability and the pore size of the clots. Differences 
in microgel residence were observed as a function of microgel size. Following this, a 
proof of principle encapsulation study was conducted using +6 GFP in order to 
investigate the role of electrostatic interactions in loading of therapeutics within the 
microgels, with possible potential in triggered release. Finally, microgels with the largest 
RH among those analyzed, conjugated to three different peptides, GPRP (fibrin knob A 
mimic), GPSP (control peptide) and AHRP (fibrin knob B mimic), were subjected to 
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flow through fibrin clots. The particles conjugated to the knob A mimic were found to 
successfully disrupt the fibrin clots. These results are promising because this is a novel 
system that exploits the nature of fibrin as an equilibrium polymer,
22
 in order to cause 
clot disruption in the presence of micromolar concentrations of targeting peptide density 
in less than 3 hours. We hypothesize that the multivalent display of peptide moieties on 
the microgels are responsible for this enhanced effect. Moreover, the presence of a core 
in the microgels has the potential to be loaded with a secondary therapeutic if essential, 
for supplementing fibrinolysis, or for delivering other agents that could be used in 
applications such as imaging to the clots, further improving the scope of this system. 
 
4.2 Experimental section 
 
4.2.1 Materials  
 All materials were purchased from Sigma-Aldrich unless specified otherwise. 
Details of common materials are available in Chapter 2, section 2.2.1 and Chapter 3, 
section 3.2.1. The comonomer used for shell synthesis acrylic acid (AAc, Fluka), CaCl2, 
KCl, buffer preparation material formic acid (EMD Millipore), 2-maleimidoethylamine 
trifluoroacetate salt (AEM), methacryloxyethyl thiocarbamoyl rhodamine B (mRhoB, 
Poly Fluor 570, Polysciences Inc.), human fibrinogen (FIB3, Enzyme Research 
Laboratories), human α-thrombin (Enzyme Research Laboratories, HT 1002a) and 
peptides from GenScript GPRPFPAC (GPRP), GPSPFPAC (GPSP) and AHRPYAAC 
(AHRP) were all used as received. The solutions were prepared using distilled water, 
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deionized to a resistance of 18 MΩ (Barnstead E-Pure system). Solutions were filtered 
through a 0.2-µm Acrodisc syringe filter before use. 
 
4.2.2 Microgel core synthesis  
 Microgel cores were synthesized by free radical precipitation polymerization, by a 
process similar to that described in Chapter 2, section 2.2. For the syntheses under 
consideration here, NIPMAm and BIS in molar compositions of 98% and 2% 
respectively were dissolved in 48.5 mL distilled, deionized water, to a total monomer 
concentration of 140 mM, along with SDS at the relevant concentration (refer to Table 
4.1). The resulting solution was filtered through a 0.8 µm Acrodisc syringe filter and 
synthesis was carried out in conditions identical to those described in Chapter 2, section 
2.2.2, with the only change being the introduction of 0.5 mL of a solution of mRhoB in 
DMSO, to a final concentration of 0.1 mM, once the solution temperature was stable at 
70 ⁰C. After reaction completion, the solution was cooled and then filtered through glass 
wool.  
 
4.2.3 Microgel shell synthesis  
 Core/shell microgels were synthesized using the previously established ‘seed and 
feed’ method,12,24 in a manner similar to that described in Chapter 2, section 2.2.2. The 
shell monomer solution used in this case was prepared by dissolving NIPMAm, BIS and 
AAc in feed ratios of 93%, 2% and 5% respectively, in distilled, deionized water, to a 
total monomer concentration of 50 mM, along with SDS at a total concentration of 2 
mM, and filtering it through a 0.8 µm Acrodisc syringe filter. The microgel core and 
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monomer shell mixture was heated to 70 ⁰C in a manner similar to the core synthesis and 
was initiated with 0.5 mL APS once temperature stability was achieved. After allowing it 
to proceed for 4 h under a N2 blanket, with constant stirring at 400 RPM, it was cooled 
down to room temperature and the solution was filtered through glass wool. The 
microgels were then purified by pelleting via ultracentrifugation at 104000 – 417000 × g 
for 20 – 70 minutes, depending on the microgel type. Every run of ultracentrifugation 
was followed by removal of the supernatant and resuspension in DI water. After 
repeating this process six times, the microgels were lyophilized prior to characterization. 
 
4.2.4 Dynamic Light Scattering  
 Hydrodynamic radii (RH) of the microgels were determined via dynamic light 
scattering (DLS, DynaPro, Protein Solutions). Measurements were performed in the 
following buffers: pH 7 phosphate (50 mM ionic strength), pH 7.4 HEPES (6 mM ionic 
strength), pH 3 formate (50 mM ionic strength), pH 3 formate (6 mM ionic strength), in a 
manner similar to that described in Chapter 2, section 2.2.3 
 
4.2.5 Atomic Force Microscopy  
 Atomic Force Microscopy (AFM) was performed using an MFP-3D AFM 
(Asylum Research), in a manner similar to that utilized in Chapter 2, section 2.2.4. 
Similar coverslips were cleaned and functionalized in a 1% (v/v) APTMS/absolute 
ethanol solution on a shaker table for 2 h, following which they were washed with DI 
water. The microgel solutions prepared in phosphate buffer (pH 7, 50 mM ionic strength) 
were then used for submonolayer deposition onto the glass substrates by centrifugation at 
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2250 × g for 10 – 25 minutes (depending on the microgel type)  at 25 ⁰C using a plate 
rotor. The coverslips were rinsed well with DI water and dried with nitrogen before 
imaging. 
 
4.2.6 Fibrin clot formation 
  Solutions of fibrinogen (13.51 mg/mL) and thrombin (10 U/mL) were thawed to 
room temperature. These were mixed with CaCl2 (final concentration 5 mM) and HEPES 
(final concentration 25 mM HEPES, 150 mM NaCl) to concentrations of 3 mg/mL or 2 
mg/mL (fibrinogen, size-based localization studies and clot disruption studies 
respectively) and 1 U/mL (thrombin) and clots were formed in plastic capillary tubes 
(Globe Scientific, Inc., I.D. = 0.85 mm). They were allowed to polymerize overnight in a 
humid environment, to avoid drying out of clots. For the experiments, they were cut into 
1.5 cm pieces for utilization with each sample solution. 
 
4.2.7 Permeability measurements and perfusion studies 
  Flow studies were performed using the experimental setup represented in Scheme 
4.1. HEPES buffer (same as that used for clot preparation) was first perfused through the 
1.5 cm clots and following a 15 minute equilibration, flow rates of buffer post traversal 
through the fibrin clots were measured for 3 – 5 minutes (depending on the clot formation 
conditions), from a solution reservoir height of 18 inches. Three measurements were 
made for every clot and clot permeability values were calculated using Darcy’s law, 
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where Q is the volumetric flow (m3/s), k is Darcy’s constant or the Darcy permeability 
(m2), µ is the liquid viscosity (kg/ms), A is the cross-sectional area of the clot (m2), ΔP is 
the pressure gradient across the clot (kg/ms
2
) and L is the length of the cylindrical clot 
(m). 
 Following confirmation of consistency in clot permeabilities, buffer solutions in 
the reservoirs were replaced by microgel solutions at a concentration of 0.1 mg/mL and 
were allowed to pass through the clots. After equilibration for 15 minutes, eluent 
collection was begun and was conducted every 30 minutes. The eluents were analyzed for 
their fluorescence using a plate reader (Infinite® 200 PRO NanoQuant™, Tecan Group 
LTD., San Jose, CA) at excitation and emission wavelengths of 540 nm and 575 nm, 
respectively. Following background corrections for buffer, fluorescence intensities 
normalized to that of the respective reservoir microgel solutions (0.1 mg/mL) were 
calculated. Three trials were performed and values of normalized fluorescence intensities 
are presented as averages of values obtained at the respective time points from these 
trials. Standard deviations were also obtained from these values and are presented. 
 
4.2.8 Production and purification of +6 GFP 
  Plasmids with genes encoding for +6 GFP from Prof. David Liu’s research group 
(Howard Hughes Medical Institute, Harvard University) were used for transformation of 
E.coli, following which the production and purification of the protein was performed in a 
manner similar to that utilized by Cronican et al.
25
 with slight modifications. Briefly, 
transformed E.coli were grown to an OD of 0.6 in LB broth (Lennox, Alfa Aesar), 
following which they were induced with 1 mM IPTG (Isopropyl β-D-
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thiogalactopyranoside, ThermoFisher) at 30 ⁰C for 4 h. The cells were then harvested and 
preserved as pellets at -80 ⁰C. These pellets were thawed in a solution of 1X PBS with 
2M NaCl and sonication was employed to lyse them. Following centrifugation at 10000 × 
g for 8 minutes, the supernatant was mixed with Ni-NTA resin (Fisher Scientific) for 30 
minutes at 4 ⁰C. The removal of resin by centrifugation was followed by multiple washes 
with 2 M NaCl and 20 mM imidazole (Fisher Scientific) and then a 2 M NaCl + 500 mM 
imidazole solution was used for detachment of the protein from the resin. Dialysis against 
PBS for 18 h at 4 ⁰C was then carried out, followed by SDS-PAGE staining with Simply 
Blue (ThermoFisher). 
 
4.2.9 +6 GFP encapsulation studies  
 Lyophilized core/shell microgels were weighed and resuspended in 0.20 µM +6 
GFP solution in the respective buffer (6 mM ionic strength HEPES or 150 mM ionic 
strength HEPES). After a 20 h equilibration, the microgel solutions were centrifuged at 
104000 – 417000 × g for 20 – 70 minutes, depending on the microgel type. The 
supernatants were analyzed for presence of +6 GFP by fluorescence measurements at λex 
= 475 nm and λex = 520 nm. Normalization was performed against stock +6 GFP 
solutions in the respective buffer conditions. 
 
4.2.10 Conjugation of peptides to microgels  
 Microgels (small, intermediate and large core/shell) were divided into three 
sections each and were resuspended in MES buffer (20 mM ionic strength) and 
conjugated to AEM through carbodiimide coupling, using a 2X molar excess of EDC and 
 89
NHSS and a 1:1 –COOH:AEM molar ratio, based on the theoretical number of AAc 
moieties incorporated in the microgel shells. This conjugation was allowed to proceed for 
2 h, following which dialyses for all 9 solutions were performed against MES buffer for 
15 h. The MES buffer was then replaced with phosphate buffer (pH 7, 140 mM ionic 
strength) and following equilibration for ~ 8 h, peptide conjugations to GPRP, GPSP and 
AHRP (1:0.2 molar ratio of theoretical –COOH:peptide) were performed overnight. The 
resulting solutions were dialyzed against DI water for one week and placed on a shaker 
for homogeneity. A small portion of each solution was lyophilized in order to determine 
concentration of the stock solutions. 
 
4.2.11 Clot disruption studies under flow  
 These studies were performed in a manner similar to the permeability 
measurements described in section 4.2.7. 1.5 cm fibrin clots were first analyzed for their 
consistency in permeability by conducting flow rate measurements using HEPES buffer. 
The Darcy constant k was determined for each clot, following which reservoir solutions 
(at an 18 inch height) were replaced with the respective peptide-conjugated microgel 
solutions (0.1 mg/mL). After equilibration for 10 minutes, flow rate measurements (3 
minutes each) were conducted for each microgel solution, after passage through the clot. 
This was repeated every 10 minutes until clot disruption was observed. Pictures of clots 
were also taken at various time points during the experiment. Two separate trials were 




4.3 Results and discussion 
 
4.3.1 Development and characterization of core/shell microgels with different 
dimensions 
 Core/shell microgels in three different size ranges were synthesized and analyzed. 
The shell was synthesized to have carboxylic acid functionalities that facilitate 
conjugation of pertinent moieties to the microgels with the display being predominantly 
localized to the surface. In this study, the goal was to utilize these groups for conjugation 
of fibrin-specific peptides, thus generating a micro- scale system for enabling targeted 
fibrinolysis. Three size ranges of microgels were analyzed in order to visualize their size-
based differential localization in and around the clots. The hypothesis was that the 
porosity of fibrin clots would cause differences in microgel residence in them. 
 Core/shell microgels have been synthesized using a seed-and-feed mechanism.
13
 
The synthesis conditions for small, intermediate and large core and core/shell microgels 
are presented in Table 4.1. Rhodamine was incorporated in its polymerizable form while 
synthesizing the cores, to aid microgel visualization in flow experiments. Different 
concentrations of the surfactant SDS and initiator APS were utilized in order to generate 
cores of three different sizes. Higher concentrations of both led to a decrease in size of 
the resultant microgels. The presence of a high concentration of surfactant like SDS is 
known to lead to smaller microgels through early particle stabilization.26 Additionally, a 
higher concentration of initiator causes a large number of nucleation sites to be formed, 
and this process being favored over chain propagation results in the formation of a large 
number of small microgels. 
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Core 140 - 98 2 0.1 - 8 8 
Core/Shell 50 10 93 2 - 5 2 0.5 
Intermediate 
Core 140 - 98 2 0.1 - 2 2 
Core/Shell 50 10 93 2 - 5 2 0.5 
Large 
Core 140 - 98 2 0.1 - 0.5 0.5 
Core/Shell 50 10 93 2 - 5 2 0.5 
Volume = 50cm
3
 , Temp. = 70 ⁰C, Stir rate = 400 RPM 
  
 
 Following synthesis, the core/shell microgels were purified to remove excess 
reagents, oligomers and secondary cores formed during the synthesis (disappearance of 
secondary cores was confirmed via DLS on supernatant solutions after centrifugation). 
The microgels were then deposited on pre-functionalized glass through centrifugation and 
imaged via AFM. Figure 4.1 A, B and C represent the AFM images of small core/shell (S 
C/S), intermediate core/shell (I C/S) and large core/shell (L C/S) microgels respectively. 
The differences in microgel size were evident from the images and height profiles. 
Deposition on functionalized substrates causes microgels to appear flattened, due to their 
deformability. They thus appear hemispherical, as observed in these images. The I C/S 
microgels seemed to be slightly polydisperse, but their sizes obtained through analysis of 
these images and DLS revealed that their diameters were still ‘intermediate’ between 
those of S C/S and L C/S microgels. 
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 In order to measure particle size and qualitatively assess incorporation of –COOH 
groups into microgel matrices during the syntheses, DLS measurements were performed 
in buffers of 6 mM and 50 mM ionic strength, at pH values above and below the pKa of 


















Figure 4.1. AFM height traces of S C/S, I C/S and L C/S microgels deposited on 
APTMS-functionalized glass by centrifugal deposition at 2250 × g for 10 - 25 minutes at 
25 ⁰C, depending on the microgel type. Images demonstrated spherical particles in all 
three size ranges 
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 The values from DLS measurements are presented in Figure 4.2. Microgels were 
seen to be pH responsive at both ionic strengths, demonstrating successful incorporation 
of AAc. The low magnitude of change in RH values can be attributed to the presence of   
–COOH groups only in microgel shells, which causes microgel deswelling in response to 









Figure 4.2. DLS measurements performed on S C/S (A), I C/S (B) and L C/S (C) 
microgels generated RH values that demonstrated a slightly greater magnitude of pH 
responsivity at 6 mM ionic strength, than at 50 mM ionic strength 
 
 
 Microgels were, however, observed to be slightly more responsive to changes in 
the pH, when measurements were conducted in low ionic strength (6 mM) buffers, 
compared to those taken in buffers of higher ionic strength (50 mM). This can be 
explained on the basis of partial screening of charges in the presence of a higher 
concentration of ionic species in solution, leading to inhibition of microgel deswelling 
under these conditions. 
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4.3.2 Flow experiments for analysis of size-based differential localization of 
microgels in fibrin clots 
 The abnormal formation of thrombi warrants the need for the delivery of 
thrombolytic agents to bring about clot lysis, to mitigate impedance of blood flow 
through blood vessels. The utilization of microgels for this purpose is very promising 
(refer to section 4.1). However, development of an effective system for this purpose 
requires an investigation into microgel localization in and around clots. This is vital to 
determine the efficacy of microgels for the purpose of fibrinolysis, because the rate of 
clot degradation will depend on the region of the clot from where it commences and how 
it progresses. Just as microgel size is an important parameter when considering this 
application, clot porosity also has a major role to play. The interplay between these two 
factors is thus extremely crucial, particularly because microgels are known to be 
deformable and hence have the potential to undergo more intricate interactions with the 
clots than comparable hard sphere colloids.
27
 
 Porosity of fibrin clots depends on the clot formation conditions.
28
 Thus, a higher 
starting concentration of fibrinogen leads to the formation of denser clots. Utilization of 
different thrombin concentrations also has distinct effects on the physical and mechanical 
properties of the clots, through changes in the thickness of clot fibers.29,30 In the study 
described here, microgel dispersions were allowed to flow through fibrin clots and the 
eluent was analyzed to examine microgel residence within the clots. The concentration of 
fibrinogen used was 3 mg/mL, which is close to the physiological range of ~ 2.5 mg/mL 










Scheme 4.1. Experimental setup used for examination of perfusion through fibrin clots. 
Permeability measurements on the clots were first performed using HEPES buffer and 
then the respective microgel solutions were allowed to flow through the clots 
 
 
 Scheme 4.1 represents the experimental set up for the flow studies. In a typical 
experiment, the permeability of fibrin clots was first analyzed through measurements of 
buffer flow rate through the clots. Darcy’s law, which relates the average interstitial fluid 
velocity to permeability of the medium, was used for this purpose. The average value of 
Darcy’s constant ‘k’, i.e. permeability, for all clots used in three trials of the experiment 




, which was in the same range as values that 
have been obtained for fibrin clots in previous studies.
19,31
 Once uniformity in clot 
permeabilities was ensured, the buffer solutions in reservoirs were replaced with S C/S, I 
C/S and L C/S microgel solutions at a concentration of 0.1 mg/mL. Following 
equilibration, eluents were collected at different time points and were analyzed based on 
the fluorescence of mRhoB at λex = 540 nm and λem = 575 nm. The results obtained are 














Figure 4.3. Flow studies performed on fibrin clots formed at 3 mg/mL fibrinogen and 1 
U/mL thrombin demonstrated differences in microgel-clot interactions based on particle 
size. Measurements performed at λex = 540 nm, λem = 575 nm. Fluorescence intensities 
were normalized to those of respective (S C/S, I C/S, L C/S) reservoir solutions (0.1 
mg/mL) (Values presented as average of 3 trials, error bars represent standard 
deviations of these three values) 
 
 
 Flow studies revealed differences in microgel passage and residences within fibrin 
clots, based on microgel dimensions. S C/S microgels were observed to pass through the 
clots easily, appearing in the eluent almost immediately. This suggests that these particles 
undergo minimal interactions with the clot, possibly due to their diameters being 
significantly smaller than the average pore size of the clot. I C/S microgels traversed 
through the clot slower than the S C/S microgels, appearing in the eluent only beyond the 
one hour time point and in seemingly smaller numbers. This suggests that their 
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dimensions may be in the range of the average pore size of fibrin clots formed under the 
aforementioned conditions. Thus, I C/S microgels appear to interact heavily with clot 
fibers. The variability observed with regards to the flow of I C/S microgels, between 
different trials, may be caused by two contributing factors. Firstly, while the microgel 
dimensions may be close to the average pore size of the clots, the differences in 
individual pore sizes, although subtle, may play an important role at the length scale 
under study. This may cause the microgel path through the clot to be somewhat non-
uniform and this may manifest itself in the form of variability in concentration of 
microgels in the eluent at different time points. Secondly, as mentioned in the previous 
section, dispersions of I C/S microgels were somewhat polydisperse. This may also be 
responsible for the discrepancies observed between different trials. L C/S microgels were 
unable to enter the clot and did not appear in the eluent in the five hour time frame of the 
experiment. Instead, these microgels concentrated at the entrance of the clot through the 
experiment, forming a macroscopically visible boundary (visualized via the color of 
mRhoB, similar to that observed in Figure 4.5 C). It is worth nothing that I C/S microgels 
also formed a similar boundary at the beginning of the experiment, which can be 
correlated to their absence in the eluent during the first hour. Over time, however, while 
the L C/S microgels were unable to enter the clot, the I C/S microgels were successful in 
doing so, presumably due to a combination of their size and deformability. Therefore, S 
C/S, I C/S and L C/S microgels showed variations in interactions with the clots due to the 
differences in their dimensions. When considering applicability, fibrin targeting could 
potentially be achieved by all three kinds of microgels. For the utilization of S C/S 
particles, attachment of affinity ligands may be necessary to observe interactions and 
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long term residence in the clots. Furthermore, S C/S microgels have the potential for 
utilization in targeting to internal regions of denser clots than the ones under 
consideration, with smaller pore sizes. Interactions of I C/S microgels may be enhanced 
with the conjugation of an affinity ligand on their shell, for increasing residence time for 
delivery, if required. Based on this study, L C/S microgels also may demonstrate 
potential utility for targeting with affinity ligands on their shells, with the interactions 
commencing at surfaces of the clots. Furthermore, the visibility to these interactions is 
hypothesized to be enhanced when clots of greater porosity are under consideration. 
 
4.3.3 Encapsulation of +6 GFP in core/shell microgels of different sizes 
 In order to investigate the ability of the core/shell constructs to encapsulate 
relevant therapeutics, a proof of principle study was performed with positively charged 
green fluorescent protein (GFP). GFP is a well characterized protein and has been utilized 
in innumerable biomedical examinations, since its discovery in 1962, by Shimomura et 
al.
32
 GFP has a molecular weight of ~ 27 kDa and an RH of ~ 2.3 nm,
33
 and it consists of 
11 β-strands that form a hollow cylinder. This cylinder has an α-helix along its axis, 
containing the chromophore, p-hydroxybenzylideneimidazolinone.
34,35
 This chromophore 
is formed by residues 65-67.
36,37
  
 A range of anionic and cationic supercharged variants of GFP have been 
developed by Lawrence et al. by carrying out mutations at surface-exposed residues.38 
These were developed primarily as potent delivery vehicles for functional 
macromolecules, into the cytoplasm of cells.
25,39
 In the current study, one of these 
variants, +6 GFP, was produced using genetically modified E.coli and utilized for 
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encapsulation studies in S C/S, I C/S and L C/S microgels. A positively charged variant 
was selected in order to provide an insight into the involvement of electrostatic 
interactions between the loaded protein and anionic microgels. Microgels were 
equilibrated in buffers of low and high ionic strengths containing +6 GFP, in order to 
facilitate encapsulation. The fluorescence values of supernatant solutions were analyzed 












Figure 4.4. Analysis of encapsulation of +6 GFP by S C/C, I C/S and L C/S microgels. 
Fluorescence intensities of supernatants were normalized to those of +6 GFP solutions in 
the respective buffers. Charge screening at higher ionic strength was found to be effective 
in causing differences in encapsulation (Values presented as averages of 3 measurements 
on single samples, error bars represent standard deviations in these three values) 
 
 
 Fluorescence analysis revealed low concentration of +6 GFP in the supernatant of 
microgel solutions incubated with low ionic strength (6 mM) buffer. This indicated high 
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encapsulation efficiency. In comparison, in the presence of a buffer of greater ionic 
strength (150 mM), a large amount of +6 GFP was observed to be left over in 
supernatant, indicating a lower amount of effective encapsulation. This difference may be 
attributed to greater screening of charges in the presence of a high salt concentration, thus 
effectively decreasing the electrostatic interactions between the positively charged 
protein and negatively charged microgels. The same trend was observed for S C/S, I C/S 
and L C/S microgels. These findings led us to a few different conclusions. Firstly, the 
size of +6 GFP (~ 27 kDa) is in a range that allows passage into microgels with the 
crosslinking density used in these experiments. Encapsulation experiments with 
cytochrome C have been performed earlier, using microgels with carboxylic acid groups 
distributed throughout their network, with the same crosslinking density as the microgels 
under consideration.40 However, the concentration of cytochrome C utilized for 
encapsulation was higher and the protein is slightly smaller than +6 GFP.
41
 Thus, 
encapsulation of other proteins with dimensions similar to +6 GFP into microgels may be 
feasible. Secondly, charge interactions play an important role in this encapsulation. 
 This proof of principle study provided information that can be helpful in 
developing effective methods for loading of therapeutics and implementing techniques of 
triggered release of the cargo through a change in the pH environment of the microgels. 
 
4.3.4 Clot disruption using microgels conjugated to fibrin-specific peptides 
 Fibrinogen is converted to the insoluble polymer fibrin thorough the action of 
thrombin. During this process, the fibrinopeptides in the center of the molecule are 
cleaved by the proteolytic action of thrombin, leading to the generation of ‘free’ knobs A 
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and B, which specifically interact with the holes a and b, present at the ends of the 
molecules. A cascade of linear and lateral arrangements leads to the eventual formation 
of fibrin.
1
 Even following polymerization, though, exposed holes a and b are present in 
the fibrin structure. Their presence and the specific A:a and B:a knob:hole interactions 
have been exploited in this study. 
  Fibrin specificity was imparted to microgels by conjugating peptide mimics of 
knobs A and B with amino acid sequences GPRPFPAC (GPRP) and AHRPYAAC 
(AHRP) respectively. These sequences have been studied for their fibrin specificity in the 
past.
42
 The conjugation was performed in a two step process, with the first involving 
carbodiimide coupling of a heterobifunctional, maleimide containing crosslinker to the 
microgels. This was followed by attaching the peptides to the microgels by thiol-
maleimide coupling, through the cysteines on the peptides. The purified microgel-peptide 
conjugates were then used in a flow study set up similar to the one represented in scheme 
4.1. 
 The flow studies were performed using fibrin clots made at a concentration of 2 
mg/mL fibrinogen and 1 U/mL thrombin. Prior to administering flow of microgel-peptide 
conjugates through the clots, permeability studies were conducted on the clots to ensure 
homogeneity. The Darcy constants for trials 1 and 2 represented in Figure 4.5 were found 
to be (6.3 ± 0.18)×10-13 m2 and (8.17 ± 0.30)×10-13 m2 respectively. Following this, the 
buffer solutions in the reservoirs was replaced with controls and microgel-dye conjugates, 
namely solutions of L C/S, L C/S-GPRP, L C/S-GPSP and L C/S-AHRP, at 0.1 mg/mL 
concentrations. The clots were allowed to equilibrate for 10 minutes, following which 
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flow rates of microgel solutions through the clots were measured. The results of these 
















Figure 4.5. Trial 1 (A) and trial 2 (B) for flow rate measurements of microgel solutions 
(0.1 mg/mL) following passage through fibrin clots formed at 2 mg/mL fibrinogen and 1 
U/mL thrombin concentrations. Grey lines indicate flow rate of HEPES buffer through 
the fibrin clots. Pictures of clots after passage of L C/S (C), L C/S-GPSP (D), L C/S-
AHRP (E) and L C/S-GPRP (F) solutions for 100 minutes, taken during trial 1. Red 
arrows indicate extent of microgel passage through clots, bringing about partial (D, E) or 
complete (F) clot disruption. The pictures are in agreement with corresponding flow rates 
(A). L C/S-GPRP microgels are seen to be effective in causing complete clot disruption 





 Flow rate measurements over time and pictures of clots taken revealed an initial 
gradual increase in flow rate of solution, followed by the complete disruption of fibrin 
clots by L C/S-GPRP microgels, over the course of the experiment (Figure 4.5 A, B, F). 
The commencement of disruption may be assigned at the time point where the increase in 
flow rate is appreciably higher than that of passage of HEPES buffer through the fibrin 
clot. Beyond this point, there is a dramatic increase in flow rate. This can be explained in 
the following manner. It has been assumed, for a long time, that fibrin clot formation is 
irreversible and that clot disruption can occur only in the presence of the active enzyme 
plasmin or under non-physiological conditions. The presence of GPRP during 
polymerization, has been known to inhibit polymer formation through competition with 
the knobs A for interactions with the complementary holes.42 However, after clot 
formation, the effect of GPRP on fibrin has only been studied briefly. In 2012, Chernysh 
et al. conducted experiments using fluorescence recovery after photobleaching (FRAP), 
to demonstrate that fibrin clots behave as equilibrium polymers.
22
 They observed that 
bleached regions of clots regained fluorescence in ~ 2 seconds, and thus they 
hypothesized that fibrin monomers and/or oligomers dissociate and associate with the 
fibers, behaving as a dynamic system, as opposed to one that is irreversible. Passage of 
solutions of GPRP though the clot was seen to cause the formation of free fiber ends and 
at high enough concentrations of GPRP (0.1 mM), the fibrin was seen to dissolve. Bale et 
al. had similarly observed a decrease in storage moduli of the fibrin clots when 5.8 mM 
GPRP solution was diffused into them, eventually leading to clot liquefaction after two 
days.
43
 It is worthwhile to note that the clots utilized in both these studies were formed 
under different conditions and changes in fibrinogen and thrombin concentrations are 
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known to affect properties of resulting fibrin clots.
28,30
 Nevertheless, the dissolution of 
the clots observed in the experiments presented in this chapter, can be explained by the 
occurrence of similar phenomena. The presence of deformable microgels with 
multivalent display of peptides presumably increases the probability of adjacent, 
dissociated junctions being simultaneously occupied by GPRP moieties on the microgels, 
leading to an enhanced effect of the phenomena observed by Chernysh et al. and Bale et 
al. Based on the theoretical moles of AAc, assuming 100% efficiency of peptide 
conjugation, the upper limit of GPRP concentration in a 0.1 mg/mL microgel-peptide 
conjugate solution is in the micromolar range, which is at least two orders of magnitude 
below the free GPRP concentrations used by the aforementioned groups. Additionally, 
complete clot disruption is observed to take place in less than 3 hours from the beginning 
of the flow experiment. This further explains the importance of the role played by 
multivalency of the microgels. The absence of changes in flow rate when solutions of L 
C/S microgels were utilized is evidence that peptide interactions with the fibrin clot are 
responsible for the dissolution. There are differences in the time taken for disruption, 
seen in the two trials represented in Figure 4.5. These may be explained on the basis of 
the sensitivity of this technique to small variations in clot permeabilities. Also, L C/S-
AHRP and L C/S-GPSP microgels are also seen to increase flow rate of solution through 
the clots, indicating partial clot dissolution (Figure 4.5 E, D respectively). Complete 
dissolution was not observed in both these cases within the time period of the experiment 
and additional experiments need to be conducted in order to study the phenomenon in 
detail over a longer time frame. However, partial dissolution may be explained in the 
following manner. Firstly, AHRP is known to be a peptide that interacts with the holes b 
 105
in fibrin. As Bale et al. noted, if a knob B-specific peptide disrupts B:b interactions, the 
disruptions are not effective enough to cause large changes in clot moduli. Additionally, 
AHRP is known to have a lower binding affinity to fibrin than GPRP.
42,44
 These may 
therefore be contributing factors towards partial or slower clot dissolution. The GPSP 
peptide may be causing partial dissolution due to the similarity in its sequence to GPRP. 
It may not, thus, be a ‘control’ with null interactions with the clots. 
 The experiments conducted, thus indicate the potential of microgel-peptide 
conjugates to be used as fibrinolytic agents themselves. This is very promising because 
the presence of peptides on their surface can ensure selective, quick lytic action, only on 
thrombi. Additionally, the encapsulation of a secondary therapeutic in the cores of the 
microgels can be employed. This could be a thrombolytic agent such as tPA. More 
complex systems could include encapsulation of a fibrin-specific imaging agent to be 
delivered at the site, for enhanced efficacy. 
 
4.4 Conclusion 
 We have developed core/shell microgels in three different size ranges, to be used 
as fibrinolytic agents. The incorporation of carboxylic acid groups in the shells of these 
particles was qualitatively assessed through an analysis of their pH responsivity at two 
different ionic strengths. Following this, flow studies were conducted, which revealed 
differential residence of microgels in the fibrin clots, depending on the differences 
between their size and clot porosity. A proof of principle encapsulation study was 
performed using +6 GFP, in order to demonstrate the involvement of electrostatic  
interactions in loading therapeutics within microgels. Finally, we demonstrated that 
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conjugation of knob A peptide mimics to the L C/S microgels generated constructs 
capable of disrupting fibrin clots through competition with the knobs A on fibrin 
monomers. This competition was for intermolecular interactions with the holes a, 
generated during equilibrium dissociation and association of monomers and/or oligomers. 
The multivalent display of GPRP peptides on microgels likely plays an important role in 
this disruption, through increasing the probability of the presence of GPRP in the vicinity 
of multiple adjacent A:a sites, leading to a faster rate of clot dissolution, at a lower 
overall concentration of peptide in the dispersion, in comparison to previous studies. 
These constructs thus have the ability to target and dissolve fibrin clots. Moreover, they 
also have the capability of being loaded with relevant imaging agents for visualization of 
fibrin clots, or with supplemental thrombolytic agents, with possible pH triggered 
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OUTLOOK AND FUTURE DIRECTIONS 
 
5.1 Development of cationic microgels for dye conjugation and high intensity 
photoacoustic signal generation 
 Chapter 2 focused on the development of functional cationic microgels of 
different sizes and degrees of functionality, for utilization in conjugation reactions. The 
generation of similar, stable colloidal systems in a reproducible manner has been difficult 
in the past,
1,2
 and hence detailed characterization of these constructs was very important. 
Therefore, we conducted studies that generated data regarding the efficiency of 
incorporation of amine groups within microgel matrices during synthesis. Chapter 3 dealt 
with the development and thorough characterization of one model cationic, amine 
functionalized microgel system, which was further used for the conjugation of two 
different dyes with potential applications in photoacoustic imaging. 
 Microgel-dye conjugates are extremely promising systems for the development of 
high intensity photoacoustic signals. This is because, through conjugation of multiple dye 
molecules within the polymer network, microgels can increase the local concentration of 
contrast agents, while their overall concentration in solution remains low. A point source 
such as a laser can thus theoretically irradiate a single particle and generate signal 
equivalent to that obtained from a much higher solution concentration of the contrast 
agent. This is particularly important when considering that dyes like malachite green and 
rose bengal, though extremely suitable for photoacoustics, are toxic to cells at higher 




Therefore, any system that eliminates the need to use such dyes at toxic levels would be 
advantageous and deserving of further development. However, currently, the 
photoacoustic signals obtained from this system were not reliable due to interference 
from the background. Hence, a crucial step to be taken before making changes in the 
structure or properties of the microgel constructs, would be the generation of 
reproducible signals, through optimization of the current signal generation system. Once 
this is accomplished, generation of photoacoustic signals from single microgels will be 
more straightforward and following this, optimization of conditions, with the use of laser 
power below the maximum permissible exposure (MPE, which depends on the 
wavelength of the laser and time of exposure) can be achieved. For rose bengal, 
utilization of a secondary laser for improving signal intensity via modulation can also be 
done.6 Furthermore, dyes that are more biofriendly can be utilized. 
 When considering further development of the microgel construct, an important 
step forward could involve the introduction of degradable crosslinkers within microgel 
matrices. The versatility of microgel syntheses provides several opportunities for this, as 
has been demonstrated by the development of a number of degradable microgel 
constructs in the past. The degradation could be triggered by the microgel environment 
and it could be a slower, controlled process or it could occur almost instantaneously as an 
immediate response to a stimulus.7-10 This could potentially generate constructs that can 
be cleared from the body following imaging. However, in order to ensure their survival 
until their purpose is served, preliminary investigations can involve the analysis of 
changes in photoacoustic signals generated over time and changes induced during 
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degradation. The degradability of the eventual construct may thus need to be tuned, with 
the use of multiple crosslinkers, for this balance to be achieved. 
 Photoacoustic imaging is a promising technique that has the capability to generate 
high resolution images of pathological abnormalities located several centimeters below 
the surface of the skin. However, when introducing imaging agents such as the microgel-
dye conjugates under consideration into biological systems, very often, they are cleared 
by the immune system before they reach the relevant region of the body.
11
 A future step 
could thus involve the development of microgels entirely synthesized from a polymer like 
poly(ethyleneglycol) (PEG). PEG has been demonstrated to be biocompatible and 
recently, the development of PEG-based microgels and their characterization has gained 
increasing interest.12-15 Comonomers containing functional groups can also be introduced 
in such microgels and thus, dye conjugations to PEG-based microgels can also be carried 
out. Similarly, degradable crosslinkers may also be introduced in the polymer matrices of 
these microgels for reasons similar to those mentioned above.  
 Additionally, microgels provide the capability to introduce specific targeting 
moieties on them, through covalent conjugations. Therefore, another interesting avenue 
to explore would involve the development of particles conjugated to dye and targeting 
moieties in the optimum ratios. The two species could also be localized in spatially 
distinct regions of the microgels, by using microgels with suitably segregated regions.16 
Such constructs can be utilized for dual functionality in the form of targeting and 
imaging. This targeting can be to utilized for carrying out imaging of tumors, early 
detection of specific molecular markers,
17-20




 Thus, cationic microgel constructs for utilization in conjugation reactions have 
tremendous promise. The ‘toolbox’ of such particles described in Chapter 2 provides the 
opportunity to select suitable microgels for conjugation, with a preliminary analysis of 
the availability of their functional groups for dye conjugations provided in Chapter 3. A 
number of arenas can be explored by modifying these constructs, as described above, for 
executing well-controlled conjugations and generating multifunctional constructs. 
 
5.2 Microgels conjugated to fibrin-specific peptides as agents of thrombolysis 
 Chapter 4 looked at the development of core/shell microgels in three different size 
ranges, with carboxylic acid groups in their shells, for utilization as agents of 
thrombolysis. These microgels demonstrated differences in their interactions with fibrin 
clots as observed through perfusion experiments of microgel solutions through fibrin 
clots. These diverse interactions were a result of the differences between microgel 
dimensions and clot porosities. A proof of principle encapsulation study with +6 GFP 
showed that electrostatic interactions were involved in loading into these anionic 
microgels, demonstrating that they have the potential to be used in release of loaded 
cargo triggered by a change in pH or ionic strength. Microgels conjugated to the GPRP 
peptide, which is known to have strong interactions with fibrin, were found to 
successfully disrupt fibrin clots. It was hypothesized that they were able to do this merely 
through multiple simultaneous peptide-clot interactions, by taking advantage of the 
equilibrium nature of fibrin clots
22,23
 and competing with momentarily dissociated sites, 
otherwise involved in fiber formation. 
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 The implications of these results are manifold and yet, a number of studies remain 
to be done, first in order to understand the intricacies of the processes involved in clot 
disruption and second, to utilize and optimize this system for temporally controlled and 
well understood outcomes. 
 While a basic understanding of the processes involved in remodeling of fibrin 
clots post polymerization is available,
22,23
 and it has been explored to some extent,
24
 the 
studies that have been performed are limited. Additionally, this is the first example of 
systems like microgels that are able to disrupt clots at a faster rate than systems 
investigated before, chiefly due to their multivalency, and without the aid of additional 
agents. This makes it more important to study the role of peptide density, microgel 
deformability and the relationship between clot porosity, microgel dimensions and the 
rate of clot dissolution. In order to understand these processes in greater detail, the 
utilization of computational modeling may prove to be extremely beneficial. This is 
because it may provide an insight into the kinetics of the interactions and the probability 
of adjacent knob:hole interactions being disrupted with the peptides on microgels 
simultaneously interfering with them. Thus, information about distance required between 
surface presented peptides and the role of microgel surface area, can also be obtained. 
 In order to fully understand the processes involved in clot disruption by 
microgels, visualization of the process will be necessary. An experimental setup that 
utilizes microfluidics combined with confocal imaging can provide details about 
microgel-clot interactions. For a better understanding, fluorophores such as 5-
iodoacetamidofluorescein (5-IAF) may be attached to the peptides for better visualization 
of interactions. These experiments would need be performed cautiously though, because 
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the molecular weight of the peptide moieties may be greatly affected by such 
conjugations and studies using such systems may need to operate under the assumption 
that peptide-fibrin interactions are not influenced by conjugation of such large moieties to 
the primary peptide. A setup with fluorescent peptides on microgels can also be subjected 
to fluorescence recovery after photobleaching (FRAP) experiments, similar to those 
performed by Chernysh et al.
22
 This may provide further insight into the rate of 
association and dissociation of monomers and oligomers, and the role played by specific 
spatial organization of microgel-conjugated peptides in the vicinity of these processes. 
 A large number of flow experiments also remain to be performed for a better 
understanding of these interactions. An important experiment will involve the utilization 
of small core/shell (S C/S) microgels in denser clots and examining possible clot 
degradation. If surface areas of the microgels that present peptides, play a vital role, huge 
differences may be visible between the types of clots degraded and rates of clot 
degradation (if observed) acquired when using S C/S microgels vs. the large particles 
utilized in the experiments in Chapter 4. Furthermore, differences in peptide densities on 
particles surfaces may also play a crucial role in determining the role of microgel surface 
area in these phenomena. Lastly, when considering such variations, the importance of 
microgel deformability through changes in crosslinker contents and the utilization of 
conventional microgels with functionalities throughout their matrix, may provide 
important information about microgel movement through clots and the necessity of 
surface localization of the peptides. 
 An important factor that has not been investigated in the current experiments is 




Experiments that have been conducted by other groups, demonstrating fibrin remodeling 
have been performed on non-ligated clots. It has been observed that covalent ligation, in 
essence, causes the clot formation to become irreversible and thus no fiber dissociation or 
clot dissolution has been observed for such clots. When considering the clots utilized in 
the experiments presented in Chapter 4, the fibrinogen used contained ~ 8 Loewy units of 
factor XIII per mg (Enzyme Research Laboratories). In comparison to the physiological 
concentration of factor XIII in plasma, (~ 100 Loewy units/mL),
26
 this is at least an order 
of magnitude lower. Therefore, an interesting experiment would involve the introduction 
of factor XIII at physiological concentrations in flow experiments similar to those 
described in Chapter 4. Since microgels appear to be more efficient than free peptide, in 
clot disruption, they may be able to disrupt clots that have been covalently ligated. 
Perhaps their multivalency can take these studies a step further and a system can be 
developed, that may be capable of dissolving seemingly irreversible fibrin clots. 
Disruption of such clots has not been demonstrated before and thus, establishing a system 
that could perform such complex lysis would have abundant applications in developing 
highly efficient fibrinolytics. 
 Finally, the utilization of core/shell microgels in this study opens up possibilities 
to encapsulate additional theranostic agents. For example, supplemental fibrinolytic 
agents, such as tissue-type plasminogen activator (tPA), for site-specific release and 
faster clot disruption may be loaded into the microgels. Alternately, agents for 
simultaneous imaging, such as those that have been used for visualization of fibrin clots 
before,
27,28
 may be released at the site of clots, having been delivered to the site by 
targeted microgel carriers. 
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 The development of targeted systems for delivery of thrombolytic agents has 
progressed due to the necessity to diminish their off-target effects. However, the 
microgel-peptide systems described in Chapter 4 are unique in their ability to target and 
disrupt clots without the use of additional fibrinolytic agents. A number of future studies 
need to be conducted in order to understand the complex processes involved in this clot 
dissolution, in detail. Therefore, several computational and experimental investigations 





(1) Thaiboonrod, S.; Berkland, C.; Milani, A. H.; Ulijn, R.; Saunders, B. R.: 
Poly(vinylamine) microgels: pH-responsive particles with high primary amine contents. 
Soft Matter 2013, 9, 3920-3930. 
 
(2) Farley, R.; Saunders, B. R.: A general method for functionalisation of microgel 
particles with primary amines using click chemistry. Polymer 2014, 55, 471-480. 
 
(3) Dhamgaye, S.; Devaux, F.; Manoharlal, R.; Vandeputte, P.; Shah, A. H.; Singh, 
A.; Blugeon, C.; Sanglard, D.; Prasad, R.: In Vitro Effect of Malachite Green on Candida 
albicans Involves Multiple Pathways and Transcriptional Regulators UPC2 and STP2. 
Antimicrob. Agents Chemother. 2012, 56, 495-506. 
 
(4) Lambert, C.; Sarna, T.; Truscott, T. G.: Rose-bengal radicals and their reactivity. 
J. Chem. Soc.-Faraday Trans. 1990, 86, 3879-3882. 
 
(5) Culp, S. J.; Beland, F. A.: Malachite green: A toxicological review. J. Am. Coll. 
Toxicol. 1996, 15, 219-238. 
 
 120
(6) Richards, C. I.; Hsiang, J. C.; Dickson, R. M.: Synchronously Amplified 
Fluorescence Image Recovery (SAFIRe). J. Phys. Chem. B 2010, 114, 660-665. 
 
(7) Jo, Y. S.; Gantz, J.; Hubbell, J. A.; Lutolf, M. P.: Tailoring hydrogel degradation 
and drug release via neighboring amino acid controlled ester hydrolysis. Soft Matter 
2009, 5, 440-446. 
 
(8) Turturro, M. V.; Christenson, M. C.; Larson, J. C.; Young, D. A.; Brey, E. M.; 
Papavasiliou, G.: MMP-Sensitive PEG Diacrylate Hydrogels with Spatial Variations in 
Matrix Properties Stimulate Directional Vascular Sprout Formation. Plos One 2013, 8. 
 
(9) Nayak, S.; Gan, D. J.; Serpe, M. J.; Lyon, L. A.: Hollow thermoresponsive 
microgels. Small 2005, 1, 416-421. 
 
(10) South, A. B.; Lyon, L. A.: Direct Observation of Microgel Erosion via in-Liquid 
Atomic Force Microscopy. Chemistry of Materials 2010, 22, 3300-3306. 
 
(11) Juliano, R. L.: Factors affecting the clearance kinetics and tissue distribution of 
liposomes, microspheres and emulsions. Adv. Drug Delivery Rev. 1988, 2, 31-54. 
 
(12) Zhou, T.; Wu, W. T.; Zhou, S. Q.: Engineering oligo(ethylene glycol)-based 
thermosensitive microgels for drug delivery applications. Polymer 2010, 51, 3926-3933. 
 
(13) Lutz, J. F.: Thermo-Switchable Materials Prepared Using the OEGMA-Platform. 
Adv. Mater. 2011, 23, 2237-2243. 
 
(14) Chi, C. L.; Cai, T.; Hu, Z. B.: Oligo(ethylene glycol)-Based Thermoresponsive 
Core-Shell Microgels. Langmuir 2009, 25, 3814-3819. 
 
(15) Pikabea, A.; Ramos, J.; Forcada, J.: Production of Cationic Nanogels with 
Potential Use in Controlled Drug Delivery. Particle & Particle Systems Characterization 
2014, 31, 101-109. 
 
(16) Seiffert, S.; Romanowsky, M. B.; Weitz, D. A.: Janus Microgels Produced from 
Functional Precursor Polymers. Langmuir 2010, 26, 14842-14847. 
 
 121
(17) Kumar, S.; Richards-Kortum, R.: Optical molecular imaging agents for cancer 
diagnostics and therapeutics. Nanomedicine (London, U. K.) 2006, 1, 23-30. 
 
(18) Nayak, S.; Lee, H.; Chmielewski, J.; Lyon, L. A.: Folate-mediated cell targeting 
and cytotoxicity using thermoresponsive microgels. J. Am. Chem. Soc. 2004, 126, 10258-
10259. 
 
(19) Lu, S.; Neoh, K. G.; Huang, C.; Shi, Z.; Kang, E.-T.: Polyacrylamide hybrid 
nanogels for targeted cancer chemotherapy via co-delivery of gold nanoparticles and 
MTX. J. Colloid Interface Sci. 2013, 412, 46-55. 
 
(20) Das, M.; Mardyani, S.; Chan, W. C. W.; Kumacheva, E.: Biofunctionalized pH-
responsive microgels for cancer cell targeting: Rational design. Adv. Mater. (Weinheim, 
Ger.) 2006, 18, 80-83. 
 
(21) Lanza, G. M.; Abendschein, D. R.; Hall, C. S.; Marsh, J. N.; Scott, M. J.; 
Scherrer, D. E.; Wickline, S. A.: Molecular imaging of stretch-induced tissue factor 
expression in carotid arteries with intravascular ultrasound. Invest. Radiol. 2000, 35, 227-
234. 
  
(22) Chernysh, I. N.; Nagaswami, C.; Purohit, P. K.; Weisel, J. W.: Fibrin Clots Are 
Equilibrium Polymers That Can Be Remodeled Without Proteolytic Digestion. Sci Rep 
2012, 2. 
 
(23) Bale, M. D.; Muller, M. F.; Ferry, J. D.: Effects of fibrinogen-binding 
tetrapeptides on mechanical-properties of fine fibrin clots. Proc. Natl. Acad. Sci. U. S. A. 
1985, 82, 1410-1413. 
 
(24) Walker, J. M.; Zaleski, J. M.: Non-Enzymatic Remodeling of Fibrin Biopolymers 
via Photothermally Triggered Radical-Generating Nanoparticles. Chemistry of Materials 
2014, 26, 5120-5130. 
 





(26) Mosesson, M. W.; Siebenlist, K. R.; Hernandez, I.; Lee, K. N.; Christiansen, V. 
J.; McKee, P. A.: Evidence that α2-antiplasmin becomes covalently ligated to plasma 
fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation. 
Journal of thrombosis and haemostasis : JTH 2008, 6, 1565-1570. 
 
(27) Pan, D.; Pramanik, M.; Senpan, A.; Yang, X.; Song, K. H.; Scott, M. J.; Zhang, 
H.; Gaffney, P. J.; Wickline, S. A.; Wang, L. V.; Lanza, G. M.: Molecular Photoacoustic 
Tomography with Colloidal Nanobeacons. Angew. Chem., Int. Ed. 2009, 48, 4170-4173, 
S4170/1-S4170/9. 
 
(28) Pan, D.; Senpan, A.; Caruthers, S. D.; Williams, T. A.; Scott, M. J.; Gaffney, P. 
J.; Wickline, S. A.; Lanza, G. M.: Sensitive and efficient detection of thrombus with 






THE DEVELOPMENT OF ULTRALOW CROSSLINKED 




Portions adapted from 
 
Bachman, H.*; Brown, A. C.*; Clarke, K. C.*; Dhada, K. S.*; Douglas, A.*; Hansen, C. 
E.*; Herman, E.*; Hyatt, J. S.*; Kodlekere, P.*; Meng, Z. Y.*; Saxena, S.*; Spears, M. 
W.*; Welsch, N.*; Lyon, L. A.: Ultrasoft, highly deformable microgels. Soft Matter 
2015, 11, 2018-2028. 





 Traditionally, NIPAm (N-isopropylacrylamide) based microgels are synthesized 
in the presence of a crosslinking agent, such as N,N’-methylenebisacrylamide (BIS). 
Microgel crosslinking modulates individual microgel mechanical properties. Below their 
lower critical solution temperature (LCST), pNIPAm microgels crosslinked with 2 mol % 
BIS were found to have a Young's modulus of approximately 80 kPa, compared to 10 
mol % BIS crosslinked particles, which were found to have a Young's modulus of 
approximately 500 kPa.
1
 In 2003, Gao and Frisken demonstrated that ultra-low 
crosslinked (ULC) pNIPAm microgels could be synthesized under ‘crosslinker free’ 
conditions.
2
 These particles are self-crosslinked through a chain transfer reaction at the 
tert-carbon sites which could occur on either the pendent isopropyl group or on the main 
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chain backbone. These chain transfer reactions are rare, and therefore these particles have 
extremely low (<0.5%) degrees of crosslinking, which appears to be core localized. 
Previous studies have demonstrated that size and solid density of self-crosslinked 
pNIPAm microgels can be finely tuned by controlling reaction temperatures, monomer 
and initiator concentrations.3 Because crosslinking affects microgel mechanical 
properties, we hypothesized that ULC microgels would be softer and more deformable 
than traditionally crosslinked microgels. Microparticle elastic modulus affects numerous 
biological responses including in vivo dynamics, cellular uptake and extracellular 
matrix interactions. For example, soft microparticles resembling red blood cells in size 
have longer circulation times than rigid microparticles of an identical size.
4
 Furthermore, 
hydrogel nanoparticle elasticity has been shown to influence macrophage uptake. Banquy 
et al. recently demonstrated that soft nanoparticles with Young's moduli of ~ 18 kPa were 
internalized through macropinocytosis, nanoparticles with Young's moduli between 35 
and 130 kPa were internalized via clathrin and/or caveolae-mediated endocytosis, and 
stiff nanoparticles with Young's moduli of ~ 200 kPa were internalized through clathrin-
mediated endocytosis.
5
 The enhanced spreading capability of ULC particles compared to 
crosslinked particles is presumed to be due to an increased degree of deformability due to 
the exceedingly low connectivity of ULC microgels. Herein, the deformation of ULC 
particles is characterized by AFM analysis of spreading on glass surfaces and the ability 
to translocate through nanopores significantly smaller than the hydrodynamic diameter of 
the particles. The data presented here particularly deals with neutral ULC particles 
(NULCs) and small ULC particles (SULCs). 
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A.2 Synthesis of NULCs and SULCs 
 NULCs-1 and NULCs-2 were synthesized under the exact same conditions, in a 
manner similar to a traditional microgel synthesis (refer to Chapter 2, section 2.2.2), with 
a total NIPAm concentration of 100 mM. The two syntheses were initiated using different 
concentrations of the anionic initiator ammonium persulfate (APS): 0.5 mM and 8 mM 
respectively. 
 SULCs-1 and SULCs-2 were synthesized in a similar manner, but with 5 mol % 
acrylic acid (AAc). In both these syntheses, the concentration of APS used was the same 
(1 mM). The concentration of surfactant sodium dodecyl sulfate (SDS) utilized was 
varied (0.2 mM for SULC-1 and 1 mM for SULC-2). Microgels were purified by 
centrifugation. 
 
A.3 Neutral ULCs (NULCs) 
 NULCs were synthesized in two different size ranges, denoted as NULCs-1 and 
NULCs-2, by varying initiator concentration while leaving all other synthesis conditions 
unaltered. NULC size was characterized via DLS, AFM and qNano analysis. AFM 
imaging of NULCs-1 deposited under conditions of active and passive deposition 
indicated that the microgels spread significantly on the glass surface, with the spreading 
being most pronounced under conditions of active deposition when the microgels were at 
sub-monolayer conditions (Figure A.1, A–D). While NULCs-2 deposited readily under 
packed conditions, they could not be deposited as a sub-monolayer, suggesting that 
microgel–microgel interactions are preferred over microgel–surface interactions. When 
deposited as a packed monolayer, NULCs-2 were found to have a height of 11 ± 2 nm 
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Table A.1 Size characterization of NULCs 
 NULCs-1 NULCs-2 
Hydrodynamic Radius 
(nm):  DLS 











(µm) : AFM 
Passive 
deposition 
1.58 ± 0.11 1.23 ± 0.07 N/A 2.65 ± 0.24 
Active 
deposition 





16 ± 1 15 ± 2 N/A 11 ± 2 
Active 
deposition 



























Figure A.1. AFM height traces of Neutral ULCs (NULCs) deposited on APTMS-
functionalized glass under different conditions. (A) NULCs-1 deposited by passive 
deposition for 1 h from a 20 mg/mL solution. (B) NULCs-1 deposited by active 
deposition at 2250 × g for 30 minutes from a 0.1 mg/mL solution. (C) NULCs-1 
deposited by passive deposition for 3 h from a 0.1 mg/mL solution. (D) NULCs-1 
deposited by active deposition at 2250 × g for 7 minutes from a 0.1 mg/mL solution. (E) 
NULCs-2 deposited by passive deposition for 1 h from a 10 mg/mL solution. (F) 
NULCs-2 deposited by active deposition at 2250 × g for 1 minute from a 0.1 mg/mL 
solution. All images are 20 µm × 20 µm  
 
 
 Hydrodynamic radii of NULCs-1 and NULCs-2 were 469 ± 29 nm and 723 ± 48 
nm, respectively, and radii determined through qNano, were 434 ± 91 nm and 348 ±153 
nm, respectively. The similarities in radii measurements via DLS and qNano for NULCs-
1 suggest behavior characteristic of less deformable particles. NULCs-2, however, appear 
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to be more deformable, and like anionic ULCs, have physical radii that are considerably 
smaller than their hydrodynamic radii. While the two types of NULCs behave differently 
due to differences in their sizes and network structures, they nevertheless demonstrate the 
deformability that is characteristic of ULCs, albeit to different extents. 
 
A.4 Small ULCs (SULCs) 
 In addition to their charge, the size of ULCs can also be modulated. Small ULCs 
(SULCs) with diameters less than a micron were obtained by performing syntheses in the 
presence of a surfactant. Modification of the surfactant concentration yielded SULCs of 
two different sizes: SULCs-1 with a hydrodynamic radius of 409 ± 18 nm and SULCs-2 
with a hydrodynamic radius of 211 ± 4 nm. SULCs-1 were found to have a radius of 164 
± 22 nm through qNano analysis, however, SULCs-2 were not detectable with this 
method, even using the smallest pore size available for the system (~ 100 nm in 
diameter). We conclude that due to the small size and deformability of these particles, the 
smallest pore size available does not hinder translocation of SULCs-2, resulting in 
undetectable translocation events. AFM imaging on SULCs-1 revealed the presence of a 
second, minor population of particles, slightly larger than the SULCs-1 themselves 
(Figure A.2 A). The spreading of both SULCs-1 and SULCs-2 on a flat surface was also 
observed via AFM imaging, and these particles were found to have spread radii of 805 ± 
105 nm and 395 ± 55 nm, respectively, and heights of 10 ± 1 nm and 3 ± 1 nm, 




Table A.2 AFM image analysis of SULCs 
 SULC-1 SULC-2 
Diameter (µm) : AFM 1.61 ± 0.21 0.79 ± 0.11 














Figure A.2. AFM height traces of SULCs deposited on APTMS functionalized glass. (A) 
SULCs-1 deposited by active deposition at 2250 × g for 10 minutes from a 0.0001 
mg/mL solution. (B) SULCs-2 deposited by active deposition at 2250 × g for 10 minutes 
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ADDITIONAL CHARACTERIZATION OF CATIONIC 
MICROGELS AND MICROGEL-DYE CONJUGATES 
 
 













































Figure B.1. AFM height traces of microgels synthesized with [NaCl] (A) and [APS] (B) 
above a threshold (specific to the synthesis conditions) leads to the formation of 
misshapen particles (all images are 20µm × 20µm). Microgels were deposited on 





















Figure B.2. AFM height trace of µgelPEG (A), representative height profile (B) and RH 
measured in buffers of different pH values (C). Microgels were deposited on APTMS-
functionalized glass by centrifugal deposition at 2250 × g for 15 minutes at 25 ⁰C 
 133
 Analysis of µgelPEG using the CBQCA assay revealed the number of moles of 
APMA in the analyzed solution to be (1.97 ± 0.04)×10
-8
, with the efficiency of primary 
amine incorporation being 39 ± 1 %. 
 


















Figure B.3. pH titration curves of µgel2 solutions using 0.101 M HCl as a titrant for 
quantification of primary amine groups 
 
 
 pH titrations were performed using a Vernier pH Electrode and LabQuest 
Software (Vernier Software and Technology, LLC., Beaverton, OR).  Microgels were 
diluted to a total concentration of 1 mg/mL in 20 mL distilled, deionized water. Titration 
was performed against 0.101 M HCl (standardized against 0.099 M Na2CO3) under a N2 
purge with stirring, at ambient temperature. Measurements of solution pH were made 
after 300 s equilibration following each addition of titrant. 
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Scheme B.2. Conjugation reactions utilized for synthesis of µgel2a-MGITC (A) and 



























Figure B.4. Standard curves for absorbance measurements of malachite green 














Figure B.5. AFM height traces of µgel1-RB (A), µgel2-RB (B) and µgel6-RB (C) 




Table B.1 Deswelling data for µgel2b-RB at 37 ⁰C vs. 20 ⁰C 
 
Temperature (⁰C) RH (nm) 
20 401 ± 21 
37 349 ± 18 
Values obtained at pH 7 (Phosphate buffer, 50 mM ionic strength) 
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 The average percent deswelling of the microgels is 33.33% by volume, 
demonstrating that as a result of pNIPMAm having an LCST of ~ 44 ⁰C, the microgels 
are not completely deswollen at physiological temperature. 
 





















Figure B.6. Viability data for NIH3T3 fibroblasts incubated for 24 h with unconjugated 
microgels (blue bars), microgels conjugated to malachite green (green bars) and 
























Figure B.7. Photoacoustic signals generated from µgel2a-MGITC (A) and µgel2b-RB 
(B) conjugates incorporated into tissue phantoms (Aida Demissie, Dickson research 
group, Georgia Tech)  
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APPENDIX C 
NANOGELS AS VEHICLES FOR TARGETED DELIVERY OF 
SIRNA TO DRUG RESISTANT OVARIAN CANCER CELLS 
 
C.1 Core/shell nanogel synthesis and characterization 
 Core/shell nanogels were synthesized using a previously established procedure.
1,2
 
The synthesis was performed in a manner similar to that described in Chapter 2, section 












Figure C.1. RH distribution of core/shell nanogels obtained via dynamic light scattering 






C.2 Peptide conjugation to nanogels 
 Peptides were conjugated to nanogels using a two step approach, similar to that 
used before.2 The first step involved covalent conjugation of a heterobifunctional 
crosslinker, 6-maleimidohexanoic acid (EMCA) by carbodiimide coupling, to the amine 
functionalized nanogel shells. This was followed by conjugation of the relevant peptide, 
YSA (YSAYPDSVPMMSC) or its scrambled version SCR (DYPSMAMYSPSVC) 
through thiol-maleimide coupling. 
 
 
C.3 In vitro and in vivo studies 










Figure C.2. Delivery of siRNA into HeyA8 tumors. YSA-nanogels were co-injected with 
or without iRGD via the tail vein into mice, and the tumors harvested and sectioned. 
YSA-nanogels (green) and blood vessels stained with CD31 (magenta) (a) YSA-nanogels 
+iRGD (b) and analysis of YSA-nanogel to CD31 pixel area (Image J) demonstrating 















Figure C.3. Uptake of YSA-nanogels by individual tumor cells, determined by flow 
cytometry. The relative nanogel fluorescence values for all groups (N=3, 2 mg/mouse 
injected) were normalized by using the Mean Fluorescent Intensity (MFI) from each 
sample and dividing it by the tumor weight (grams). Values were determined in the 
absence (nanogels) and presence of iRGD. CTL=Control cells, no nanogels present; 
SCR=nanogels linked to the SCR peptide, used as a control for non-specific uptake of 
nanogels; YSA=nanogels linked to the YSA peptide to direct the nanogel payload to 





























Figure C.4. Distribution of YSA-nanogels in HeyA8 tumors and mouse tissues after 
injection of YSA-nanogels alone or in the presence of iRGD. Three mice were used for 
each treatment group, and the relative nanogel fluorescence in tumor and tissue lysates 
compared to untreated controls is presented 
  
 
 The data presented in figures C.2, C.3 and C.4 indicated that co-administration of 
YSA-conjugated nanogels with iRGD, a tumor penetrating peptide, increased nanogel 
uptake in tumor cells and tumors. This can be leveraged towards efficient delivery of 
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